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ABSTRACT 
The Na,K-ATPase, or Na+ pump is an integral membrane prote in found in the 
cells ofvirtually aIl higher eukaryotes and is one of the most important systems in 
cellular energy transduction. Na,K-ATPase catalyzes the electrogenic exchange 
of three intracellular Na + for two extracellular K+ ions coupled to the hydrolysis of 
one molecule of A TP. The research described in this thesis concems the 
regulation of the Na,K-A TPase by FXYD 2, a member of the FXYD family of 
small single transmembrane proteins. FXYD 2, commonly known as the y 
modulator, is located primarily in the kidney and has a role in modulating the 
enzyme's apparent affinities for ligands. This study has addressed several aspects 
of y structure and function, namely its function in intact ce Ils, the function of the y 
transmembrane domain, and delineation of regions of the enzyme's catalytic a 
subunit with which y interacts. Transport assays using intact transfected HeLa 
cells showed that the two y variants, ya and yb, cause (i) an increase in K+ /Na + 
antagonism, seen as an increase in K'Na at high K+ concentration, and (ii) an 
increase in apparent A TP affinity seen as an increase in ouabain-sensitive K+ 
influx as a function of A TP concentration. These results are consistent with those 
obtained earlier with unsided membrane preparations. The present study also 
showed a y-mediated increase in steady-state intracellular Na + concentration and, 
in contrast to assays using permeabilized membranes, a y-mediated increase in 
apparent affinity for extracellular K+. Experiments with synthetic y 
transmembrane (y-TM) peptides provided insight into the role of the TM region 
1Il 
such that incubation of the se peptides with membranes containing aj3 pumps 
modulated K'Na similarly to transfected full-Iength y, indicating that the TM 
domain alone can cause an in crea se in K'Na at high K+ concentration. Results 
with y-TM bearing the Gll l -7 Arg missense mutation associated with familial 
renal hypomagnesemia provided direct evidence that this mutation prevents y 
association with aj3 pumps. In a study aimed to identify regions of a critical for 
the functional effects of y, interactions of al/a2 (and the reverse a2/al) chimeras 
with y showed the importance of the carboxy terminus, particularly TM 9. The 
chimera data also indicate that interactions of transmembrane regions of the 
catalytic a subunit with FXYD proteins are not necessarily the sole determinants 
of the kinetic effects of y on Na + affinity since the extramembranous L 7/8 loop of 
a appears to modulate intramembranous a-y interactions that mediated the 
increase in K+lNa+ antagonism. 
iv 
RÉSUMÉ 
La Na,K-ATPase, ou pompe à sodium, est une protéine membranaire intégrale 
exprimée par les cellules de presque tous les eucaryotes supérieurs, et est un des 
systèmes les plus importants impliqués dans la transduction d'énergie cellulaire. 
La Na,K-ATPase catalyse l'échange électrogénique de trois Na+ intracellulaires 
pour deux K+ extracellulaires grâce à l'énergie fournie par l'hydrolyse d'une 
molécule d'ATP. Les recherches décrites dans cette thèse concernent la 
régulation de la Na,K-ATPase par FXYD 2, un membre de la famille des petites 
protéines membranaires FXYD. FXYD 2, communément admise comme le 
modulateur y, est située principalement dans le rein; elle est connue pour moduler 
les affinités apparentes de l'enzyme pour ses ligands. Cette étude vise plusieurs 
aspects de la structure et de la fonction de la sous-unité y, en particulier sa 
fonction dans les cellules intactes, le rôle du domaine transmembranaire de y, et 
les régions de la sous-unité catalytique a de la Na,K-ATPase avec laquelle y 
interagit. Les études de transport utilisant des cellules HeLa intactes démontrent 
que les deux variants, ya et yb, causent (i) une augmentation de l'antagonisme 
K+/Na+, vue comme une augmentation de K'Na à haute concentration de K+, et (ii) 
une augmentation de l'affinité apparente pour l'A TP, vue comme une 
augmentation de l'afflux sensible à la ouabaïne de K+ en fonction de la 
concentration d'ATP. Ces deux observations sont compatibles avec les résultats 
obtenus à partir de préparations de membranes non polarisées. Les résultats ont 
également montré une augmentation de la concentration cytoplasmique en Na + 
v 
grâce à y, et contrairement aux résultats obtenus avec des préparations de 
membranes non polarisées, indiquent une diminution de K'K(ext) provoquée par y. 
Les études utilisant des peptides transmembranaires synthétiques de y (y-TM) ont 
fourni de l'information quant au rôle de sa région transmembranaire (TM). 
L'incubation de ces peptides avec des membranes contenant des pompes aj3 induit 
la modulation de K'Na de la même façon que dans les cellules transfectées avec y 
intègre, ce qui semble indiquer que seul le domaine transmembranaire peut causer 
une augmentation de K'Na à une haute concentration de K+. Les résultats obtenus 
avec le y-TM portant la mutation de Glll~Arg associé à une forme 
d'hypomagnésémie rénale familiale, indique que cette mutation empêche 
l'association de y avec aj3. Une étude visant à identifier les régions critiques de la 
sous-unité a interagissant avec y a montré l'importance de l'extrémité C-terminale 
du peptide, en particulier TM 9; les expériences ont été menées en utilisant des 
chimères al/a2 ainsi que les chimères inverses a2/al. Les résultats indiquent 
également que les interactions entre les régions transmembranaires de la sous-
unité catalytique avec des protéines de FXYD ne sont pas nécessairement les 
déterminants uniques des effets cinétiques de y sur l'affinité de Na+ pour la Na,K-
A TPase. Il semble en effet que la boucle extramembranaire L 7/8 module aussi 
les interactions a-y intramembranaires pour induire une augmentation de 
l'antagonisme K+/Na+. 
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CHAPTERl 
INTRODUCTION 
1.1 PREFACE 
In 1997, Skou was awarded the Nobel Prize for his discovery of the Na,K-
A TPase. The publication of thousands of reports each year relevant to various 
aspects of Na,K-A TPase structure and function underscores the impact of this 
discovery. Maintenance of ionic homeostasis, namely a high intracellular K+ 
concentration (~150mM) and low intracellular Na+ (~1O-20mM), is largely 
accomplished by the Na,K-ATPase which is the main consumer of ATP in 
mammalian cells (64). As a result, this transport creates the electrochemical 
gradient across the cell membrane that is essential for various cellular functions 
such as fluid reabsorption, electrolyte homeostasis in the kidney and maintenance 
of the resting potential in excitable cells. The Na + gradient created by the Na,K-
A TPase is also the driving force for secondary active transport processes 
necessary for the reabsorption of many solutes. 
The focus ofthis thesis is on regulation of the Na,K-ATPase by FXYD 2, 
commonly known as the y modulator. The Introduction provides a brief overview 
of the structure and mechanism of the Na,K-ATPase and pump regulation with 
emphasis on modulation of the Na,K-ATPase by y, a member of the FXYD family 
of small single transmembrane proteins. This thesis is manuscript-based, in 
accordance with Section C of the Faculty of Graduate Studies and Research 
Guidelines for Thesis Preparation. Chapters 2, 3 and 4 are published manuscripts. 
As such, Chapters 2 to 4 contain their own reference lists, and Chapter 7 contains 
references for the Introduction and General Discussion. In addition, in 
compliance with section C, paragraph 2, Chapters 2 to 4 contain a preface which 
2 
includes "connecting texts that provide logical bridges between the different 
papers". 
3 
1.2 The Na,K-ATPase 
1.2.1. ATP-driven ion pumps 
The Na,K-ATPase, also known as the Na+ pump, is a member of the P2 
subfamily of a larger P-type A TPase family. P-type ATPases differ from the 
vacuolar or V-type ATPases and from the multimeric, ATP synthesizing, F-type 
pumps in that they form a phosphorylated intermediate in the course of their 
reaction cycle. During the reaction cycle, the enzyme undergoes conformational 
changes of both phosphoenzyme and dephosphoenzyme, i.e. EIP ---+ E2P and El 
---+ E2 respectively. 
The P-type A TPase family comprises more than 300 members. In recent 
years many different classification schemes have been proposed that are based on 
the type of ion transported and similarity in structure. In the particular 
classification discussed here, P-type A TPases are divided into three groups. 
Members of the PI subfamily transport transition metals or metalloid compounds 
(Cd, Cu, Ag), while those of the P2 subfamily transport alkali metal cations such 
as Na+, K+, and other cations, namely Ca2+ and H+. Examples ofmembers of the 
latter subfamily of ion pumps that transport biologically significant cations are the 
gastric mucosa H,K-ATPase, a close relative of the Na,K-ATPase, and the Ca-
A TPases of plasma membrane and sarco( endo )plasmic reticulum (SERCA). It is 
interesting to note that the Na,K-ATPase and the gastric H,K-ATPase are not only 
the closest relatives in terms of amino acid sequence identity, but also are P-type 
ATPases composed of two essential subunits (23, 47). The P3 subtype is 
composed of a sole member, KdpB from E. coli, which provides K+-
4 
accumulation. Classification into these subfamilies is based on the location ofkey 
sequences in and around the A TP binding domain. 
1.2.2. Structure of Na,K-ATPase 
1.2.2.a. The (l subunit 
The larger of the two subunits is the catalytic a subunit which is composed 
of approximately 1000 amino acids and has a molecular mass of about 110 kDa. 
As the catalytic subunit, it contains the binding sites for cations, A TP and 
ouabain. The a subunit comprises 10 transmembrane domains with both 
cytoplasmic N-and C- termini (56). Many studies have provided insights into the 
transmembrane topology of the a subunit (3, 18, 83, 85, 104, 112, 13 l, 142, 148). 
They predict an N-terminal segment with four transmembrane domains, a large 
cytoplasmic domain which comprises approximately 30% of the protein and a C-
terminal domain consisting of 6 transmembrane domains. This membrane 
topology is similar to that predicted for other P2-type A TPases such as the Ca- and 
H,K-ATPases (18, 22). 
The alignment of the Na,K-ATPase to the high resolution crystral structure 
of SERCA demonstrates notable structural similarities. A recent review discusses 
these similarities as weIl as sorne of the differences (132). In terms of the high 
resolution structure of SERCA published by Toyoshima and coworkers (139) 
there are three cytoplasmic domains of the catalytic subunit that have notable 
function. These regions correspond to the N or nucleotide-binding domain, the P 
or phosphorylation domain and the A or actuator domain. The N and P domains 
5 
are located in the TM 4-TM Sloop (L4/5), while the A domain is formed by the 
N-terminus and the L2/3 loop. The extracellular loops are short with the 
exception of the L7/8 loop. This loop in the Na,K-ATPase has been shown to 
provide important contacts for association of a with the ~ subunit (29, 77, 110, 
144). 
The catalytic a subunits of P2-type A TPases also share several other 
structural similarities. These conserved domains, believed to be involved in 
communication between A TP hydrolysis and conformational change (the energy 
transduction domain), ion binding and ATP binding (105) include: (i) the large 
cytoplasmic loop between transmembrane helices 4 and 5 (L4/5) containing the 
A TP binding and phosphorylation sites, (ii) a highly conserved hinge region at the 
junction of the L4/5 loop and TM 5, and (iii) a ~-strand region in the minor loop 
between TM 2 and TM 3 (L2/3). Within these domains exist several highly 
conserved amino acid sequences, namely (i) the DKTGT(LlIN/M)(T/1/S) motif in 
the catalytic loop, which contains the aspartate (D) which defines membership in 
P-type ATPase family, (ii) a TGE(S/A) sequence in the L2/3 loop prior to the 
phosphorylation site (89, 91), (iii) a GDGXNDXP motif immediately after the 
ATP binding domain, and (iv) P(EN)GL in TM 4 which is essential to energy 
transduction (24). The TGE(S/A)- and DKTG-containing regions are within the 
A and P domains described by the SERCA crystal structure (139). 
6 
1.2.2.b. The J3 subunit 
The J3 subunit is a single transmembrane protein with its short N-terminus 
facing the intracellular space, a single transmembrane domain and a long 
extracellular C-terminal domain (i.e. type II membrane protein). It is fully 
glycosylated on ail three potential N-glycosylation sites and in addition there are 3 
disulfide bridges in the extracellular domain. It is composed of approximately 
370 amino acids and has a mass of about 55 kDa. 
The function of the J3 subunit is not entirely clear. It has been shown that 
J3 acts as a chaperone to ensure the proper folding, insertion and maturation of the 
a subunit in the plasma membrane (1, 23, 49, 107) and it appears that both a and 
J3 subunits are essential for ouabain-sensitive Na,K-ATPase activity (33). There is 
evidence that deglycosylation causes no loss in activity (10) and has no effect on 
J3 protein levels at the membrane's surface (149), which is in contrast to the J3 
subunit of the gastric H,K-ATPase where removal of glycosylation sites results in 
the loss of enzymatic activity (72). However, reduction of disulfide bridges by J3-
mercaptoethanol or DTT results in a loss of enzymatic activity (69, 71, 88). The J3 
subunit may also play a role in stabilizing the K+-occluded state of the enzyme 
(88). While the presence of the J3 subunit may play sorne role in determining the 
kinetic characteristics of mature pumps, major kinetic differences are most likely 
the result of tissue-specific differences in a isoform composition (see 1.2.2.d. 
below). 
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1.2.2.c. Tertiary and Quartenary Structure of the Na,K-ATPase 
The minimal structure required for N a,K -A TPase activity comprises a 
membrane-associated complex of the two subunits, a and 13, which are present at 
a 1:1 ratio (64). There is debate regarding the oligomeric structure of the Na,K-
ATPase (117). It has been demonstrated that the al3 dimer is capable of 
catalyzing the complete reaction cycle (143), and that this is the naturally 
occuring form, at least in the red blood cell (98, 119). However, other evidence 
supports the ide a that in other systems, the enzyme functions as a (a 13)2 
heterodimer or possibly as a (al3)4, tetramer (15, 65,86, 128, 140). 
The a and 13 subunits are synthesized independently and assembled in the 
endoplasmic reticulum (ER) (1). This involves the interaction of several domains 
of each subunit. The essential interactions occur between the ectodomain of 13 and 
the highly conserved SYGQ motif in the extracellular L7/8 loop of a, (9, 28, 77), 
and between the transmembrane domain of 13 and TM 8 of the a subunit (109). In 
addition, Geering et al. (50) showed that part of the N-terminal tail of 13 may also 
be involved in interactions with a, although it is not likely to be essential to 
proper pump folding. For a detailed review of the role of the 13 subunit in P-type 
A TPases, see ref. 47. 
1.2.2.d. Isoforms of the Na,K-ATPase subunits 
First cloned in sheep (126), the amino acid sequence of a has also been 
deduced for rat, chicken and human (36, 84, 121, 125, 129). Three major 
isoforms have been identified, namely al, a2 and a3. Across species there is an 
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overall high level of amino acid sequence identity for all isoforms (~ 90%). There 
is also a high degree of identity among the a isoforms (~80%). Most divergent 
regions include the N-terminus as well as the large cytoplasmic L4/5 loop. 
Shamraj and Lingrel (123) identified a fourth a isoform in rat testis, a4, and it is 
the most divergent, sharing only 78% identity with al. 
The a isoforms are expressed in a tissue- as weIl as development- specifie 
manner; for review see ref. 16. In terms of expressed protein, in rat, al is 
ubiquitously expressed, a2 is found in adipocytes (57, 75, 90), brain (99), glial 
cells, choroid plexus (151) and adult heart (90), while a3 is predominantly 
expressed in nervous tissue and in fetal heart (55). Expression of a4 is restricted 
to the testis. The tissue expression pattern of the Na,K-ATPase a4 isoform is one 
of the most restricted, having been identified only in mouse, rat, and human testes 
and at lower Ievels in mouse epididymis (123, 141). 
Isoform diversity also exists for the J3 subunit. The J3 subunit is also 
expressed in a tissue- and developmental-specific manner; for review see ref. 16. 
To-date, three J3 isoforms have been identified in mammals, namely J31, J32 and 
J33. These forms of J3 have been found in many vertebrates such as such as rats, 
mice, birds and human (14, 51, 76, 97). The J31 isoform is ubiquitous, J32 is found 
in skeletal muscle, pineal gland and nervous tissue and J33 is found in testis, 
retina, liver and Iing. Unlike the a subunit, amino acid sequence homology is low 
for the J3 isoforms. There is only a 34% identity between J31 and J32, whereas 
sequence identity is 39% for J33 and J31. Highest sequence identity (49 %) is seen 
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between J32 and J33. The homology of J3l and J32 isoforms is 95% across 
mammalian species and drops to 60% when nonmammalian species are included 
in the comparison (16). It is interesting to note that the protein sequence 
similarity between J32 and the J3-isoform of the H,K-ATPase is greater than the 
similarity between the J32 and J3l isoform of the Na,K-ATPase. The 
transmembrane domain of the J3 subunit is the most conserved region among 
isoforms and species. 
Information regarding expression, function and regulation of the Na,K-
ATPase isoforms has grown extensively over the years. For more extensive 
reviews of the Na,K-ATPase structure and mechanism, see refs. 66 and 68. For a 
review focusing on the functional properties of multiple isoforms and their 
possible physiological relevance see ref. 16. 
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Fig. 1-1: Tertiary structure of the Na,K-ATPase. 
Scheme of the membrane topology of the a and f3 subunits of the Na,K-ATPase. 
The a subunit consists of 10 TM domains (grey rectangles) while the f3 subunit is 
a single TM protein (represented by the black rectangle). The sites of 
glycosylation (Q') and the disulfide bridges (-) of the f3 subunit are shown. 
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1.2.3. Function of the Na,K- ATPase 
Enzyme cycle 
Many studies have been conducted to determine the various transport 
reactions of the pump, the properties of the reaction intermediates and to identify 
the amino acid residues and domains that are important for ligand binding and 
conformational transitions. The pump can be made to function in a variety of 
non-physiological modes by manipulating experimental conditions. In its normal 
mode of operation, the Na,K-ATPase exchanges three Na+ ions from the 
cytoplasm for two K+ ions from the extracellular space. Un der physiological 
conditions, the forward reaction operates against the electrochemical gradient of 
both the transported ions. During its reaction cycle, the Na,K-ATPase proceeds 
through several different conformations as it interacts with its ligands. The 
Albert-Post model describing the basic reaction cycle is shown in Fig. 1-2. 
Briefly, in the El conformation, the enzyme binds Na+ and ATP (with 
high affinity). Hydrolysis of ATP leads to direct phosphorylation of the enzyme 
and the release of ADP. The three Na+ ions become occluded within the enzyme 
which renders them inaccessible from either side of the membrane. The enzyme 
then undergoes a spontaneous conformational change [EIP(3Na) ---+ E2P + 3Na] as 
it releases the Na + ions into the extracellular milieu. In the E2P form, the enzyme 
has a higher affinity for K+ and a low affinity for ATP. Successive binding oftwo 
K+ ions to E2P accelerates dephosphorylation and the two K+ ions become 
occluded [E2P + 2K+ ---+E2P(2K)---+E2(2K)]. Deocclusion of two K+ ions occurs 
slowly in a spontaneous reaction which is greatly accelerated by low affinity A TP 
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binding to E2(2K). Deocclusion is folIowed by the release of K+ into the 
cytoplasm. The enzyme is now poised in El again and ready for another cycle. 
AlI steps are reversible. Under normal circumstances, the turnover rate of the 
enzyme is about 10,000 min- I (see, for example, ref. 64). 
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Fig. 1-2: Albers-Post model of the Na,K-ATPase enzyme cycle. 
Occluded cations are represented by brackets. This cycle represents the normal, 
physiological cycle. Stoichiometry of ion transport not shown; three intracellular 
Na + ions are released to the extracellular space while two K+ ions are transported 
to the cytoplasmic side. 
Na+ CYT 
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1.3 REGULATION OF THE Na,K-ATPase 
1.3.1. Overview of Na,K-ATPase regulation 
The Na,K-A TPase is a major regulator of intracellular sodium 
concentration ([Na+]in). Consequently, the sodium gradient created by the Na,K-
A TPase also plays an important role in secondary active transport systems such as 
the Na+ICa2+- and Na+/H+- exchanger, thus regulating cell volume, cytoplasmic 
pH and calcium levels. Hence the Na + pump is likely to be a major target of 
regulation. Over the last few decades, most efforts were directed to the study of 
the structure and function of the Na,K-ATPase enzyme. In more recent years 
considerable attention has been focused on its regulation, particularly in relation 
to tissue-specific requirements. To-date known regulators include hormones, 
cytoskeletal components and other associated membrane components. Whereas 
long-term changes in pump activity may be the result of altered rates of 
translation, transcription or RNA stability, short-term changes may reflect 
modulations in the kinetic properties/substrate affinities, cell surface expression 
and stability. 
Regulators such as hormones can exert their modulatory effects on the 
Na,K-ATPase through signalling mechanisms. Activation of key signalling 
molecules like PKA and PKC by hormones initiates signal cascades whose 
downstream effect is to modulate Na + pump activity. The mechanisms by which 
these hormones and kinases affect Na,K-ATPase activity have been described in 
detail in Therien and Blostein (134) and a detailed review specific to hormonal 
regulation and activation of signalling mechanisms in the kidney was written by 
Feraille and Doucet (38). 
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The focus ofthis thesis is the regulation of the Na,K-ATPase by members 
of the FXYD family of small single TM proteins. Accordingly, the following 
discussion is focused on the FXYD family of proteins, with special emphasis on 
the y modulator which was the first FXYD protein reported to associate with and 
regulate the Na,K-ATPase, and it is one of the best characterized members to-
date. 
1.3.2. FXYD family of proteins 
1.3.2.a. Primary structure and sequence homology 
FXYD proteins belong to a gene family of smaIl, single transmembrane 
proteins that appear to modulate the Na,K-ATPase and possibly other 
transporters. Analysis of more than 1000 related ESTs (expressed sequence tag) 
defined at least seven known members, namely FXYD's 1-7, each possessing a 35 
amino acid signature sequence that includes 6 invariant amino acids before, in and 
after the transmembrane domain in aIl family members and species. These 
include the N-terminal FXYD (Phe-X-Tyr-Asp) motif, along with two glycines in 
the TM domain and a serine in the C-terminal domain. FXYD proteins are not an 
integral part of the Na,K-ATPase but to-date severa] have been shown to 
modu]ate the catalytic properties of the pump through association in a tissue-
specific manner. A detailed ana]ysis of the gene transcripts in the EST database 
of the members of this family is discussed in ]ength (130). Figure 1-3 shows the 
rat protein sequences of FXYD family members. 
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The y modulator of the Na,K-ATPase is, to-date, the best characterized 
FXYD member. Other identified members include: Mat-8 (mammary tumor 
marker) (106), CHIF (corticosteroid hormone induced factor) (6), RIC (42) and 
PLM (phospholemman) (111). PLMS has been identified in shark rectal glands 
(94). 
Analysis of membrane topology of FXYD members showed that they are 
type 1 membrane proteins such that the N-terminus is extracellular and the C-
terminus is cytoplasmic. It should be noted that Mat-8 (FXYD 3) can contain two 
transmembrane domains presumably due to the lack of cleavage of a signal 
peptide and RIC (FXYD 5) has an unusually long N-terminus. 
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Fig. 1-3: Rat sequence alignment of FXYD proteins. 
Conserved amino acids are underlined 
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Table 1-1: Major Tissues Expressing FXYD proteins 
FXYD prote in 
FXYD 1 1 
Phospholemman 
(PLM) 
FXYD21 
y 
FXYD 3 1 
Mammary tumor (Mat-8) 
FXYD41 
Corticosteroid Hormone Inducing Factor 
(CHIF) 
FXYD 5 1 
Related to Ion Channel 
(RIC) , 
Dysadherin 
FXYD61 
Phosphohippolin 
(Php) 
Tissue 
Distribution 
brain, heart, 
kidney 
kidney 
stomach 
·············1········· 
kidney, colon 
References 
(40, 147, 
150) 
(113,114, 
146) 
(32) 
(46, 113, 
124) 
.. 1-------
kidney, intestine, (87) 
Jung, heart, spleen 
CNS (67) 
............................... ····························1··· ....... _ •............•........•...... - ..... 
FXYD7 brain (12) 
PLMS shark rectal gland (93) 
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1.3.2.b. Tissue specifie distribution 
Initial EST databank analysis also revealed tissue-specific distribution of 
FXYD family members. A detailed summary of the tissue distribution of FXYD 
proteins at the mRNA and protein level can be found in a more recent review 
(45). As se en in Table 1-1, FXYD proteins are abundant in tissues involved in 
active ion transport such as brain, kidney and heart. While sorne FXYD members 
are expressed in the same organ, they do not always show colocalization in the 
same region ofthat particular organ. For instance, y and CHIF are predominantly 
expressed in the kidney. Immunohistochemistry of rat kidney showed that y is 
expressed at highest levels in the thick ascending loop of Henle (TAL) while 
CHIF is highly expressed along the cortical collecting duct (CCD) principal cells 
as weIl as the outer and inner medullary collecting ducts (37). 
1.3.2.c. Interactions with the Na,K-ATPase and other ion transport proteins 
For many years, the renal Na,K-ATPase was known to contain a 
proteolipid, later referred to as the y subunit (27, 116, 118). First considered a 
contamination of the membrane purification procedure, actual association to the 
Na + pump was convincingly shown by covalent labeling with photoreactive 
derivatives of ouabain (41). Mercer and co-workers isolated and characterized the 
cDNAs of y from several speCles and In addition, they showed 
coimmunoprecipitation of Œ, f3 and y demonstrating specific association (l02). 
However, the functional and physiological significance remained unknown for 
many years. Thus, until the late 1990's FXYD proteins were not identified as a 
22 
group of ion transport regulators and their functional effects had not been 
elucidated. 
In the last decade, it has been shown that FXYD's 1-4, 7 and PLMS 
associate with the Na,K-ATPase. Conflicting data exist in terms ofthe number of 
FXYD proteins that may interact with each aJ3 complex. Coimmunoprecipitation 
experiments of y- and/or CHIF-transfected HeLa cells using detergent conditions 
shown to optimize efficiency (C l2EIO in the presence ofRb+/ouabain) indicate that 
the a:J3:FXYD ratio is close to 1:1:1 and that heterodimeric complexes do not 
exist in these detergent conditions (46, 80). Others have reported the presence of 
heterodimeric complexes (5) when solubilized in Cl2E8. It is not known how the 
protein complex exists in the native membrane. 
There is an increasing body of evidence indicating multiple sites of 
interaction between FXYD proteins and the Na,K-ATPase. Mutagenesis 
experiments in the Xenopus oocyte system (lI, 13) showed that the extracellular 
FXYD motif is necessary for the efficient association of y and CHIF with the 
pump. These authors also showed that the positively charged residues in the 
cytoplasmic tail are necessary for y' s efficient association and for CHIF's 
functional effects. 
Other experiments using a series of y-CHIF chimeras (80) coexpressed 
with the rat a1J31 complex indicated that the stability of a-FXYD associations 
was dependent on the origin of the FXYD TM segment. Thus, chimeras 
containing only the TM domain of CHIF are less stable (Iike CHIF itselt) 
compared to chimeras comprising only y-TM. It was concluded that residues 
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A34, 144 and L45 in the TM reglOn of y are important for the increased 
efficiency/stability of its association with the Na+ pump. A helical wheel 
projection of the aforementioned residues (135) indicates that A34 and L45 face 
the same direction, while 145 is oriented at an angle of approximately 100°, 
pointing to multiple sites of interaction with either a and/or 13. 
The question of where in the al3 complex FXYD proteins interact has been 
a major issue of investigation. A thermal denaturation experiment suggested that 
y may interact with a region that inc1udes TM's 8-10 (34). Later, cryoelectron 
microscopy of the renal Na,K-ATPase proposed that y is in a groove surrounded 
by TM 2, TM 6 and TM 9 of the a subunit (54). Using mutants of al, Li et al. 
(78) assessed association of y, CHIF and FXYD 7 with the Na,K-ATPase and 
showed that L964 and F967 in TM 9 of the a subunit are important for stable 
association with FXYD proteins (78). The mutational analysis was also in 
agreement with a docking mode) of the Na,K-ATPase/FXYD 7 complex, which 
predicted the importance of L964 and P967 in subunit interaction (78). Cross-
linking experiments also indicate the importance of residues in TM 9 of the a 
subunit for association with FXYD's (44). Based on their cross-linking data 
Fuzesi et al. (44) constructed a model showing the TM domain of y fitting into a 
groove between TM 2, TM 6 and TM 9 consistent with the above cryoelectron 
microscopy study, while the cytoplasmic tait of y interacts with loops L6/7 and 
L8/9 and stalk S5. Furthermore, they showed an interaction between 13 and y. 
More recent cross-linking experiments (81, 82) show the interaction of C138 in 
TM 2 of a 1 with FXYD (C49 of CHIF or F38C mutant of y) which fits weil with 
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aIl predicted models to-date. Modeling of the inhibitory interaction of 
phospholamban (PLN) with the Ca-ATPase by Toyoshima et al. (138) indicate 
that PLN fits into a similar groove made of TM 2, TM 6 and TM 9. 
Interestingly, recent work on shark rectal gland PLMS showed a cross-link 
between the C-terminal C74 ofPLMS and C254 in the A domain of the a. subunit 
(95). Considering the high degree of homology of the TM region of FXYD 
proteins, a model was proposed in which PLMS also resides in a pocket made up 
of TM 2, TM 6 and TM 9 as predicted for y, CHIF and FXYD 7 (95). However 
this model places C254 at the opposite face of the prote in relative to PLMS. 
Accordingly, the authors had previously suggested an alternate model in which 
PLMS is located on the opposite side of a. in a cleft comprising TM 1- TM 4. 
Presumably leucine-isoleucine zipper motifs in MIIM2 of Na, K-ATPase could 
stabilize interactions as previously suggested by Cornelius and Mahmmoud (30). 
The aforementioned studies are indicative of the complexity of the FXYD: 
Na,K-ATPase interaction. lt may turn out that the interactions of FXYD proteins 
with the Na,K-ATPase do not aU occur in the same clefts/grooves of the a. 
subunit. 
Phosphorylation of FXYD members may be another means of regulating 
their association with and modulation ofthe Na+ pump. Recently the PLMlNa,K-
A TPase interaction was studied using FRET (fluorescence energy transfer) 
between CFP-Na,K-ATPase and YFPc-PLMP fusion proteins (17). These studies 
showed a reduction in FRET foUowing phosphorylation of PLM suggesting that 
phsophorylation alters PLM's interaction with the pump to relieve inhibition. 
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PLM and its homologue PLMS are members of the FXYD family known to be 
phosphorylated by protein kinases. The C-terminus of PLMS is heavily 
phosphorylated by PKC in vitro (94), as is the case for PLM (111). 
FXYD 3 or Mat-8 can associate with the Na,K-ATPase as weIl as with 
both gastric and colonic H,K-ATPases when expressed in Xenopus oocytes (32). 
Mat-8 was shown to modulate the glycosylation of 13 of either the Na,K- or H,K-
ATPase and that this modulation was dependent on the presence ofMat-8's signal 
peptide. Since the expression of Mat-8 is restricted to mucous ce11s, in vivo 
association occurs only with Na,K-ATPase since H,K-ATPase is absent. PLM is 
another member that has been shown to coimmunoprecipitate with the Na+/Ca2+ 
exchanger (NCX) in adult rat myocytes and cause inhibition of NCX1-mediated 
currents (150). To-date a11 other FXYD members appear to associate solely with 
the Na,K-ATPase. 
1.3.2.d. Functional interactions of FXYD's with Na,K-ATPase 
Table 1-2 summarizes the functional effects of FXYD proteins on Na,K-
ATPase activity. It can be se en that the FXYD members modulate the kinetic 
activity of the enzyme by altering the apparent affinity for its substrates (i.e. Na+, 
K+ and ATP) and suggests a unique and novel mode of regulation of the Na,K-
A TPase that involves the tissue-specific expression of an auxiliary subunit. Thus, 
to-date it is assumed that FXYD proteins are tissue-specific regu1atory subunits, 
which adjust the kinetic properties of the pump to the specific needs of the 
relevant tissue or cell type. 
26 
Next to the y modulator, CHIF is the best characterized member to-date. 
The functional effects have been weIl documented in both Xenopus oocytes (11) 
and mammalian cells (46). As can be se en from Table 1-2, the effects ofCHIF on 
Na,K-ATPase are opposite to those of y. Studies in both experimental systems 
mentioned above have indicated that CHIF increases Na + affinity by about 2-fold. 
In the presence of external Na+ (90 mM), an increase in K'K at hyperpolarized 
membrane potentials was observed such that this decrease in the apparent K+ 
affinity is due to increased Na + competition at external binding sites. This effect 
ofCHIF on K'K was not detected in transfected HeLa cells (46). It is possible that 
the lack of observed effect of CHIF on K'K in HeLa cells was due to a decreased 
amount of external Na+ (30 mM) and a less polarized membrane. 
Studies on PLM have also provided sorne contradictory results that point 
to the complexity of the functional interactions that FXYD proteins have with the 
Na,K-ATPase. For instance in Xenopus, expression ofPLM results in a decrease 
in the apparent affinity for Na+ and K+ with no effect on the maximal rate (31). 
However, recent studies using sarcolemma membranes obtained from hearts of 
PLM KO mice showed a lower maximal rate with no change in apparent affinity 
for Na + (59). Furthermore, other recent work with purified complexes of a-J3-
PLM from Pichia pastoris (79) showed an increase in affinity for Na+, opposite to 
the results obtained in Xenopus oocytes. Whether or not phosphorylation states of 
PLM can account for these differences is unclear. 
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Co-expressing FXYD 5 with the al and (31 subunits of the Na,K-ATPase 
in Xenopus oocytes resulted in a 2-fold increase in pump activity, measured either 
as maximum outward CUITent or ouabain-sensitive 86Rb + uptake (87). 
Detaited reviews of the structure/function relationship between Na,K-
ATPase and FXYD proteins have recently been published (45, 48). 
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Table 1-2: Effects of FXYD proteins on Na,K-ATPase activity (modified from 
ref.45) 
FXYD prote in 
FXYD 1 1 
Phospholemman 
(PLM) 
FXYD21 
y 
Experimental 
System 
Xenopus oocytesa 
Kinetic 
Parameter 
KO.5(Na) 
Ko.5( K) 
__ ._______.Y illiP>_ ......... _ ..... _ 
Choroid plexus, KO.5(Na) 
neutralizing V max 
antibody 
Fold effect 
(FXYD/control) 
1.8 (al); 1.51 (a2) 
1.4 (al); 1.42 (a2) 
References 
(31) 
Nc:>.~h~~g(;!_ ...__ ... _ 
No change (40) 
lA 
.. __ ................. _.- ........•. _ ...... _ ... , .. _ .. - .. , ........ _....... . .......•• , .. ~ _ ... _ ... -..•. "._...... . .... _. -.... - ._--_. __ ._ .. _~_ ... _-._-_ ... _------------_._-- ... _ .... __ .. . 
KO mouse-cardiac KO.5(Na) No change (59) 
SLM______ ..... yJ!la~_____ .. _~~L_________________________ .._____ 
Cardiac SLM Vmax 2.8 (43) 
... _ ................ _ .............. __ . . ......... _-- .. -... _ ...... _-_ .... . 
Cardiac myocytes V max 
Xenopus oocytesb KO.5(K) (at-
150 mV) 
{P]1~~l?h~J'l~~i!L_ ..___ _______ ..... 
1.36 (al) 
(phosphorylated) 
0.8 (yaoryb) 
(127) 
(11) 
KO.5(K) (at - No change 
50mV) 
...____ ............ _ ......... _ ....._ .. ~Q,?Ll'Il:I) .. ..................1.:?Jy~);L~(yl:>.} ......  
Renal microsomes KATP 0.5 (136) 
± C-terminal y-
antibody 
•. _ ••••••• _ •••.•• _ .. _ ••• __ •••• _ •••.••.•••• __ •••• _._M ...... _ ••••• _ •••••••• _ ••• H.,_ •••.•• ~ ••••••• 'M~ •..• _ ... h.' •••• ~~...... • •••••••••••••••••••••• _.. • ...•.•.•.•...••• M ..... _~ .••••• ~ ......... ___ .............. _ .......... __ .... ~ 
Mammalian cell KATP 0.5 (ya or yb) (114, 137) 
membranes No change (2,4) 
KO.5(Na) 1.5 (ya)C (4) 
1.5 (ya) (114) 
1.5 (yb) 
K05(K) 1.6(yat (4) 
.... _ ................ - ................. _ .............. - ............. -....... .. ... 
Mammalian cells KATP 
K05 (Na) 
___m_______mm___ ... _~_Q,2.Œ1 __ _ 
Reconstitution KO.5(Na) 
_~!!h_l:!Ml?~ptj45!_ ................. __ _ 
KO mouse Kidney 
membranes 
K05(Na) 
K05(K) 
KATP 
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No change (ya or (114) 
yb) 
.. ...................................................................................................... -_.. . .......... _ .................. ~ ..... .. 
0.8 (yb) Ch.2 
1.7-1.9 (ya or yb) 
0.64 
2-3 Ch.3 
....... t-----~-~~- ......... - .................... -..... -............ . 
1.3 (62) 
No change 
1.3 
Experimental Kinetic Fold effect 
FXYD prote in System Parameter (FXYD/control) References 
FXYD 3 / Xenopus oocytes KO.5(Na) 1.2 (32) 
Mammary tumor KO.5(K) LI-lA 
(Mat-8) 
FXYD4/ Xenopus oocytes K05(Na) 0.6 (11) 
Corticosteroid KO.5(K) (at - 1.5 
Hormone 50mV) 
Inducing Factor 
(CHIF) 
.. _~ .... _" .. ",_ .. _ .. _._.".".-.-.. "'-""-'-'-"'-'-'" ... _ .... _ .. ........................... ................. _ •..... --~-------~ .. _~---~~ . .............................. _ ... _ ... - . ........... _ ....... 
Mammalian cells KO.5(Na) 0.3 (46) 
KO.5(K) No change 
FXYD 5 / Xenopus oocytes Vrnax 2 (87) 
Related to Ion 
Channel 
(RIC), 
Dysadherin 
FXYD 6/ n.d. n.d. 
Phosphohippolin 
(Php) 
FXYD7 Xenopus oocytes KO.5(Na) No change (12) 
KO.5(K) 1.3-1.9 (al and 
(2) 
PLMS Proteolytic Vrnax lA (a3) (93) 
digestion of C-
terminus of PLMS 
a + 
KO.5(K) measured in the presence of extracellular Na 
bEffects on KO.5(K) seen in both the presence and absence of extracellular Na + 
CIn this study the y subunit was expressed as a doublet which showed effects on 
both KO.5(Na) and KO.5(K), or as a single band which showed only the KO.5(K) effect. 
30 
1.3.3. The y modulator 
1.3.3.a. Discovery of the y modulator 
First noticed by Rivas et al. (118), the y modulator was only considered to 
be a part of the Na,K-ATPase complex following photolabelling experiments with 
2-nitro-5-azidobenzoyl (NAB) derivatives of ouabain carried out with purified pig 
kidney membranes (41), also suggesting that y may be part of the ouabain-binding 
site. It was later demonstrated that y associated in equimolar amounts with both a 
and f3 subunits (26, 53, 116). Molecular cloning and sequencing of y have been 
reported for rat, mouse, sheep and cow (102), Xenopus (13) and human (70). 
Sequence homology is high overall (~75%) and increases when mammalian 
sequences are compared (93%). 
The y modulator contains ail the conserved motifs typical of the FXYD 
family of proteins, namely F18XYD in the extracellular domain, G30G41 in the 
transmembrane region and S47X(RIK)F(RIK)C following the transmembrane 
domain. The presence of positively charged amino acids near S47 make it a likely 
target for phosphorylation by PKC. Interestingly, it has been reported that y could 
be phosphorylated by PKC in the presence of detergent (92). 
1.3.3.b. Membrane Topology and Distribution 
Early studies using N-terminal or C-terminal anti-Flag-Iabelled y binding 
to oocytes were able to detect only the N-terminus of epitope tagged y. This 
provided evidence that y is a type l membrane protein with a single 
transmembrane domain and its N-terminus facing the extracellular space (13). 
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This was further supported by Therien et al. (136) who showed trypsin sensitivity 
of the N-terminus of y in intact right-side out pig kidney microsomes. 
In 1993, Mercer et al. (102) using an immunoprecipitation approach 
demonstrated that y was a component of the Na,K-ATPase and that its distribution 
pattern parallels that of al in the nephron. Later, expression of y prote in was 
assessed in a variety of tissues, including rat glomerular ceIls, meduIla, 
axolemma, heart, red blood cells, lung, stomach, spleen and several cell lines 
derived from kidney. Using anti-y raised to the C-terminus, Therien et al. (136) 
showed that y was detected primarily in the kidney and was absent from cultured 
cells derived from renal tissue. 
1.3.3.c. y variants 
The y modulator appears as a doublet on SDS-PAGE. Doublets of y have 
been observed in kidney membranes derived from rat (4, 73), dog (102) and pig 
(108). Human y expressed in Sf-9 cells also migrated as a doublet (103). The 
presence of the doublet led to the suggestion that y is post-translationally modified 
(4) and in an earlier study (102), doublets were also observed in in vitro 
expression in the presence but not absence of pancreatic microsomes supporting 
this notion. However, further studies using mass spectrometry indicated that the 
two bands seen on SDS-PAGE of rat kidney are splice variants which differ in 
their primary sequence (73). The upper band, ya (7184 kDa) , corresponded 
closely to the published sequence (137) and the lower band was referred to as yb 
(7337 kDa). Tryptic peptide mapping and sequencing by mass spectrometry 
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revealed that the chains are identical except for their seven N-tenninal residues. 
In ya, the N-tenninal residues are TELSANH whereas in yb they are replaced by 
Ac-MDRWYL. Additional bands observed on Western blots following 
transfection are probably the result of cell-specific post-translational 
modifications (73). A third variant had been reported by Jones et al. (61) based 
on their cloning and sequencing of the mouse y gene. Analysis of the structure of 
the mouse gene showed that it encodes three tissue-specifie mRNAs that have 
distinct extracellular N-tennini but common C-tenninal and transmembrane 
reglOns. 
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Fig. 1-4: rat y variants 
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1.3.3.d. Expression and cell surface delivery of Y in various cell systems 
Yeast 
In earlier studies with pump devoid yeast cells, expression of ex and 13 
subunits with and without y failed to show any y-dependent effects on overall 
Na,K-ATPase activity. This suggested that the ex and 13 subunits are the minimal 
structural unit required for cation transport and that y is not an obligatory 
"subunit" (120). 
Amphibian oocyte 
Beguin et al. (13) using cRNA-injected Xenopus oocytes showed that y 
associates with the Na,K-ATPase ex and 13 subunits in or close to the ER and is 
transported to the membrane within 48 hours. These authors showed that 
association of y with the Na,K-ATPase is critical for y stability and delivery to the 
membrane. The expression of y did not affect cell surface expression or 
maximum transport activity of the Na + pump, as se en by the induction of similar 
pump currents when expressing either exl3 or exl3y. However, modulation of 
kinetic properties by y was observed as described in section 1.3.3.f. below. 
Inseet ceUs 
In Sf-9 cells expressing the human y subunit, single and double 
immunofluorescence staining demonstrated that y could be delivered to the 
plasma membrane independently of and with the other pump subunits and that 
this increased Na + and K+ uptake (103). Furthermore, coimmunoprecipitation of 
Sf-9 cells coexpressing y and ex subunits provided evidence for a direct interaction 
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between the two subunits. Similar results were obtained when a, J3 and y were co-
expressed. 
Expression during embryonic development 
Expression of y was investigated in preimplantation mouse development, 
where the Na,K-ATPase plays an important role in cavitation (60). Gamma 
mRNA accumulated continuously throughout aIl stages of cell development. The 
y protein localized at the blastomere surface up to the blastocyst stage, and unlike 
a and 13 subunits which accumulate at the basolateral surface, y was concentrated 
primarily at the apical surface of the polarized trophectoderm layer. When treated 
with antisense RNA complementary to y, cavitation was delayed and there was a 
reduction in ouabain-sensitive 86Rb(K+) uptake. However Na,K-ATPase activity 
was unaffected as demonstrated by direct phosphorylation assays on membrane 
preparations. 
In a study of the expression pattern of the a, 13 and y subunits during in 
vitro induction of pluripotent murine embryonic stem cells into neuronal cells, no 
mRNA for y was detectable at any stage (52). This further supports the tissue-
specific distribution and expression of y. 
In a more recent study, the expression of a, J3 and y was characterized in 
the developing Xenopus embryo (35). Each Na,K-ATPase subunit displayed a 
distinct tissue-specific and developmentally regulated expression pattern. During 
pronephric kidney development, aIl three proteins were uniformly expressed 
along the entire nephron. 
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Regulation of r expression and ceU growth 
Expression of the y modulator has been shown to be regulated by 
osmolarity. A study by Capasso and Rivard (19) using cultured inner medullary 
collecting duct (lM CD) cells showed that y was absent in cells in isotonic 
medium, but displayed a time- and osmolarity-dependent appearance in cells 
adapted to survive in hypertonic conditions (i.e. > 24 hours with NaCI 
concentrations Z 500 mOsm). The regulation is transcriptionally regulated and 
involves signalling through the PI3K and JNK2 kinase pathways since kinase 
inhibitors abolished y expression in hypertonic cells. In a later study these authors 
showed that the upregulation of the y modulator was cr dependent (21). 
Synthesis of the y modulator is also regulated at the translational level in IMCD 
cells (20). 
A role of y in cell growth is suggested by the induction ofya in cultured rat 
kidney epithelial-derived NRK-52E cells in response to hypertonicity which was 
accompanied by a decrease in cell growth (145). Expression of ya was greater in 
cells treated with sucrose than NaCI (500 mOsm). Other stress inducers such as 
heat shock (43 oC for 1 hour), heavy metal (30 !lM HgCh for 24 hours) and 
oxidative stress (1 mM hydrogen peroxide for 24 hours) also resulted in 
upregulation of ya. A significant reduction in Na,K-ATPase activity was noted 
for cell adapted to hyperosmotic conditions (a~y) compared to control (a~). 
Effects on cell growth and maximal activity were abrogated when expression of y 
was knocked down using small interfering RNA duplexes (145). Interestingly, y 
expression due to hypertonicity was also induced in cell lines from other tissues 
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such as C6 (glioma), PC12 (pheochromocytoma), and L6 (myoblasts). Taken 
together, their data suggest that expression of y may be affected in vivo by the 
ionic conditions of the kidney and may have adaptive value (145). 
1.3.3.e. Specificity of Y interaction with the Na,K-ATPase: y-a association 
In studies of coexpression of y with a and 13 using the Xenopus oocyte, y 
required association with the Na,K-ATPase for stable expression at the cell 
surface (13). Furthermore, J does not interact al one with either a or 13 subunits 
but rather requires the assembly of functional pumps (0.13). Coexpression studies 
revealed that y could interact with aIl a isoforms but not with other transporters 
like the glucose transporter (GLUT2), the rat epithelial Na channel (rENaC) and 
the gastric H,K-ATPase. Similar results were obtained for both human and rat y 
(13). No association of y with the colonic H,K-ATPase could be detected (25). 
1.3.3.f. Functional effects of the y modulator 
Evidence that y plays a direct role in modulating Na,K-ATPase activity 
was first obtained in studies with Xenopus oocytes and mammalian cells. 
Studies using membrane fragments isolated from y-transfected cells as 
weIl as rat kidney enzyme microsomes have established that y serves at least three 
distinct functions in regulating the pump. Specifically, the distinct effects of y on 
the Na,K-ATPase are (i) an increase in the apparent affinity for ATP (114, 115, 
137) (ii) an increase in the affinity for extemal K+ (see Chapter 2 and ref. 11) and 
(iii) an increase in K+/Na+ antagonism, seen as an increase in K'Na at high K+ 
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concentrations (114, 115). This last effect on Na+ affinity is underscored in recent 
studies showing that renal Na,K-ATPase from y knock-out mice displayed higher 
affinity for Na + than that from wild type animaIs (62). 
Therien et al. showed that antiserum raised against the C-terminal 
sequence of y (anti-y) partially inhibited Na,K-A TPase activity while no effect 
was detected with membranes from tissue or cultured cells which lacked 
endogenous y (136). They showed that anti-y increasingly inhibited Na,K-ATPase 
as a function of pH (inhibition increases at acidic pH under which condition the 
E2(K) ---+ El step becomes more rate-limiting), and that the oligomycin-stimulated 
increase in phosphoenzyme due to trapping of the enzyme in the El state(s) was 
greater in the presence of anti-y. Taken together, their findings suggest that y 
shifts the steady-state equilibrium towards El state(s) and that binding of the 
antibody abrogates these effects. These functional effects were also characterized 
using mock- and y-transfected HEK cells to measure (i) K'ATP of Na,K-ATPase 
activity and (ii) K+ inhibition of Na-A TPase at 1 !lM ATP which indicated that y 
increased the apparent affinity for ATP (137); an effect again counteracted by 
anti-y. 
Pu et al. also looked at the behaviour of both splice variants in an attempt 
to detect functional differences, if any, between them (114). These studies 
showed that there was no detectable differences between ya or yb with respect to 
its effect on K' ATP. These authors also showed that y decreases sensitivity to 
vanadate compared to mock -transfected a 1-HeLa cells (150 for vanadate was 
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increased ~2-fold). These results are consistent with the aforementioned 
conclusion (136, 137) that y shifts the El to E2 equilibrium in favor of El formes). 
Using electrophysiological approaches to measure Na+ current in oocytes 
Beguin et al. (11) showed that in the absence of Na +, ya and yb both produced an 
~2-fold increase in affinity for external K+ in the high negative membrane 
potential range (s -100 mV). In the presence of extracellular Na+, ya and yb 
caused an increased affinity of the Na,K-ATPase for K+ when the membrane was 
hyperpolarized (s -100 m V) and decreased K+ affinity at lower membrane 
potentials (z - 50 mV). Using al mutants Li et al. showed that F956 and E960 
were essential for the transmission of the functional effect of y on the apparent K+ 
affinity of Na,K -A TPase and that the relative contribution of these residues to the 
K+ effect differs for different FXYD proteins, probably reflecting the intrinsic 
differences of FXYD proteins on the apparent K+ affinity of Na,K-ATPase. In 
contrast, F956 and E960 were not involved in the effect of y or CHIF on the 
apparent Na + affinity (78). 
Another affect of y on Na,K-ATPase activity is observed as a decrease in 
the apparent affinity for Na + at cytoplasmic activation sites. Indirect evidence for 
this effect was seen by Therien et al. (133) in their studies directed towards 
determining tissue- versus isoform-specific differences in cation activation. 
Those experiments showed that the rat kidney enzyme exhibits high K+ /Na + 
antagonism when compared to other tissues. Later a detailed analysis ofK'Na as a 
function of K+ concentration provided strong evidence in support of the 
conclusion that the increase in K'Na reflects K+/Na+ antagonism since this effect is 
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only seen at high K+ concentrations and is the result of an increase in affinity for 
K+ at cytoplasmic activation sites rather than a direct effect on KNa. Pu et al. 
(114) showed that this holds true for both variants. 
Structure/function studies provide evidence for multiple sites of y-aJ3 
interaction involving both TM segments and the extramembranous domains of y. 
Pu et al. (115) showed the C-terminus is essential for the modulation ofK'ATP and 
that there is long range modulation by the N-terminus since N-terminal deletion 
abrogated the K' AT? effect ofy. These authors also showed that the TM region is 
important for K+ /Na + antagonism. Using a series of y-CHIF chimeras in which 
extracellular, TM and cytoplasmic domains were interchanged, it was shown that 
the effects of the FXYD-aJ3 complex on the apparent Na + affinity are determined 
by the origin of the TM domain and that the effect on K'Na is mediated by 
residues other than those that determine the stability of the complex (the se 
residues were described in section 1.3.2.b.) (80). In summary, to-date it appears 
that the TM segment mediates the effects of y and CHIF on Na+ affinity, while the 
extramembranous segments mediate the effect of y on apparent A TP affinity. 
1.3.3.g. Localization of the Na,K-ATPase a subunit and 'Y in the nephron 
Immunocytochemical approaches consisting of double label 
immunofluorescence studies (114) using an antibody directed towards the C-
terminus of y that is able to recognize both variants, and antibodies raised against 
the a subunit showed basolateral colocalization, with considerable overlap in the 
inner and outer medulla. Most notable staining for 'Y was in the latter. Expression 
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of a without y ean be se en in sorne tubule segments of the inner medulla. Taking 
advantage of the faet that the y variants differ only in their extraeellular N-
terminus, antibodies raised against the two distinct N-termini were used to 
distinguish between the spliee variants. Using these antibodies Pu et al. (114) 
demonstrated a partially overlapping but distinct expression pattern for ya and yb. 
Both are in the medullary thiek aseending limb (mTAL) and in the proximal 
tubules. The ya variant is specifie to the CCD and to eells close to the macula 
densa (MD), while yb expression is specifie to the eTAL. Strong staining for both 
a and y subunits was also seen in the distal eonvoluted tubule (DCT) (4, 146). 
Similar findings are reported elsewhere (5), are reviewed in refs. 37 and 113 and 
summarized in Fig 1-5. 
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Fig. 1-5: y variant distribution along the nephron 
Figure adapted from Farman et al. (37) 
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1.4 Goal of this study 
The mechanisms of Na,K-ATPase regulation are diverse and include the 
modulation by its association with other intrinsic membrane proteins. Amongst 
such regulators are FXYD proteins that comprise a gene family of small, single 
transmembrane proteins that modulate the kinetic behaviour of the Na,K-ATPase 
in a tissue-specific manner. This dissertation concems the regulation of the Na+ 
pump by the y modulator that exists as two main variants, ya and yb, with distinct 
as weIl as overlapping expression along the nephron. Specifically, my research 
addresses several aspects of y structure and function, namely its function in intact 
cells, the role of the y transmembrane domain, and the regions of the sodium 
pump's catalytic subunit with which y interacts. Specific goals are outlined below. 
The first goal of my research was to determine whether the modulatory 
effects of the two variants of the y modulator of the Na,K-ATPase, ya and yb, seen 
previously with unsided membrane preparations, are relevant to pump behaviour 
under more physiological conditions that prevail in intact mammalian cells. The 
approach was to use intact y-transfected cells, and to measure y effects on steady-
state [Na] in and pump-mediated 86Rb(K) influx as a function of varying 
intracellular ATP and Na + as weIl as extracellular K+ (see Chapter 2). 
Another objective of my work was to gain insight into regions of the 
transmembrane (TM) domain of y that are important for (i) trafficking/association 
with al3 pumps, (ii) the structural basis for the y-mediated increase in intracellular 
K+lNa+ antagonism seen as an increase in K'Na at high K+ concentration and (iii) 
the basis for the abrogation of y modulation by the yG41R mutation associated 
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with renal magnesium wasting. For this purpose, synthetic TM peptides of Ywt 
and Ymutant were tested directly in functional assays. Accordingly, effects on K'Na 
at high K+ concentration as weIl as association of Ywt- and Ymutant with a(3 pumps 
were determined using Ywt- and Ymutant-transfected HeLa cells (see Chapter 3). 
Another aim of my research was to determine the region(s) of a that not 
only interact(s) with the y subunit, but are aiso important for the modulatory 
effects of y. Since initial findings showed that y associated with all three major 
isoforms of a (al, a2 and a3) but increased the K'Na of al and a3 and not a2, it 
was hypothesized that regions important for function are not necessarily those 
which are important for association of y with a(3 pumps. Accordingly, 1 used an 
aI/a2 chimera approach to identify regions of a criticai for the functionai effects 
of y, in particular K+/Na+ antagonism apparent as an increase in K'Na at high K+ 
concentration (see Chapter 4). 
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CHAPTER2 
The Effect of the y Modulator on Na,K -A TPase Activity of Intact Mammalian 
Cells 
47 
2.1 PREFACE 
This manuscript has been published in the Journal of Membrane Biology 
and is titled "The Effect of the Gamma Modulator on NaIK Pump Activity of 
Intact Mammalian Cells" (Zouzoulas, A., Therien, Dunham, P.B., and Blostein, 
R. J. Membr. Biol. 204, 49-56, 2005). The goal was to determine whether the 
modulatory effects of the two variants of y, se en previously with unsided 
membrane preparations, are relevant to Na,K-ATPase behaviour under the more 
physiological conditions that prevail in intact mammalian cells. 
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2.2 ABSTRACT 
This study concems the modulatory effects of the gamma modulator of the 
NalK pump, in particular whether the effects se en in previous experiments with 
isolated membranes are relevant to NalK pump behavior in intact mammalian 
cells. For this purpose, HeLa cells previously transfected with the rat NaIK 
catalytic subunit were used. The results show that both variants of the regulator, 
ya and yb, decrease the apparent affinity of the pump for Na + and cause a mode st 
increase in apparent A TP affinity as se en in measurements of ouabain-sensitive 
86Rb(K+) influx into cells in which A TP was varied using antimycin A and 
glucose. Equivalent results had been obtained previously in our analyses ofNa,K-
ATPase activity of membrane fragments, i.e., an increase in K05(Na) at high K+ 
concentration and a decrease in K' ATP. Comparison of clones of y-transfected and 
mock-transfected cells (with similar V max values) indicated that y causes a mode st 
~30% increase in the steady-state concentration of intracellular Na+. Furthermore, 
for both ya and yb, values of intracellular Na + were similar to those predicted from 
the kinetic constants, KO.S(Na) and Vmax. Finally, there was a y-mediated increase in 
apparent affinity for extracellular K+, which had not been detected in assays of 
permeabilized membranes. 
Key words: NalK pump - y Modulator - Transport- Na,K -A TPase 
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2.3 INTRODUCTION 
The NalK pump, or Na,K-ATPase, is an integral membrane prote in found 
in virtually all cells of higher eukaryotes. It comprises two subunits, a large 
catalytic a subunit and a smaller highly glycosylated f3 subunit necessary for the 
proper folding, insertion and maturation of a in the plasma membrane. The af3 
dimer is the minimal structural unit required for N al K pump activity. 
The Na,K-ATPase catalyzes the ATP-driven electrogenic exchange of 
three intracellular Na+ ions for two extracellular K+ ions coupled to the hydrolysis 
of one molecule of ATP. It plays a key role in chemiosmotic balance and in 
maintenance of the resting membrane potential. Furthermore, the Na + gradient 
generated by this pump has a critical role in regulating intracellular pH and Ca++ 
via Na + /H+ and Na + ICa ++ exchange systems, and in the uptake of many solutes via 
Na+-coupled co-transport processes. 
Sorne of the main factors contributing to the modulation of the NalK pump 
are the enzyme's substrates (Na+, K+ and ATP), cytoskeletal components, 
endogenous digitalis-like inhibitors and hormones and the signalling cascades that 
hormones activate (24). Regulation may also occur through the association of the 
NalK pump with other intrinsic membrane proteins such as members of the 
FXYD family. This family comprises small Type 1 membrane proteins comprising 
a single transmembrane domain in which a PFXYD motif in the extramembranous 
N-terminus is invariant in cells of ail mammals (22). To date, seven FXYD 
proteins have been identified. Several have been shown to modulate the kinetic 
behaviour of the pump in a tissue-specific manner (see refs. 5, 6, 10). 
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The y modulator (FXYD2) of the renal Na,KA TPase was discovered over 
25 years ago (8), and the cDNA cloned later by Mercer et al. (17). It is the best 
characterized member of the FXYD family. It exists as two main variants, ya and 
yb. Mass spectrometry indicated that ya and yb differ only in the N-terminus (14). 
In rat kidney, ya has TELSANH and yb has Ac-MDRWYL. Sorne regions of the 
renal tubule have one or the other variant and other regions have both (2, 19,29). 
Both variants are particularly abundant in the medullary thick ascending limb. 
Previous studies from our laboratory as. weIl as others, using membrane 
fragments isolated from y-transfected rat al-HeLa or rat NRK celIs, have shown 
that y serves at least two distinct functions in regulating Na,K-ATPase activity. 
These are (i) an increase in the apparent affinity for ATP (25, 26) and (ii) a 
decrease in apparent affinity for Na + (1, 19). The latter was shown to be due 
primarily to an increase in apparent K+ affinity at cytoplasmic Na + activation sites 
(19). 
A point mutation, G41~R, in the transmembrane region of y has been 
associated with autosomal dominant renal magnesium wasting (16). Studies have 
shown that this mutation alters y association with the NalK pump through 
abnormal trafficking of y (16). Trafficking of aj3 pumps to the cell surface is not 
altered (20). 
The present study addresses the question of how the effects of ya and yb 
inferred from the experiments on unsided membrane preparations are manifested 
in the intact cell. 
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2.4 EXPERIMENTAL PROCEDURES 
Mutagenesis and Transfection- Rat ya and yb cDNAs were subcloned into the 
pIRES expression vector and transfected into HeLa cells stably expressing the rat 
al subunit of the Na,K-ATPase kindly provided by Dr. J.B Lingrel as previously 
described (19). The point mutation G41 R was introduced into yb-pIRES using the 
QuikChange Site Directed Mutagenesis Kit (Stratagene). Control rat al-HeLa 
cells were also transfected with the pIRES empty vector. 
Transport Assays- NalK pump activity was measured by determining 
unidirectional 86Rb(K+) influxes. Assays were carried out in the presence of a low 
(10 /lM) ouabain concentration to inhibit endogenous human pump activity and ± 
a high (5 mM) ouabain concentration to inhibit activity of pumps containing the 
rat al subunit and determine baseline activity (rat NalK pumps have a very low 
sensitivity to ouabain). To determine the apparent affinity for intracellular Na+, 
86Rb(K+) influxes (nmoles/mg/min) were determined in cells grown to 70-80% 
confluence on 24-well plates and assayed with various Na + concentrations and 
constant (4 mM) K+ concentration in media containing monensin (to rai se Na+ 
permeability) as described previously (18) with minor modifications (9). Briefly, 
to vary intracellular Na +, cells were preincubated for 15 minutes at 37°C with 12 
/lM monensin and 10 /lM bumetanide added to solutions with various Na + 
concentrations. For the determination of the kinetic constants for Na+ activation, 
values of 86Rb(K+) influxes expressed as functions of added extracellular Na + 
concentration were fitted to a simple one site Michaelis-Menten model (9) since it 
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was not technically feasible to detennine intracellular Na + at each concentration 
of medium Na +. The apparent affinity constant thus obtained is only a measure of 
the apparent affinity for Na + and is therefore represented as K05(Na)app (see Table 
2-1), whereas the apparent affinity for Na + calculated from previous experiments 
with membrane fragments and precisely known Na+ concentrations (Na,K-
ATPase assays) is expressed as K05(Na) (see Table 2-2). For the detennination of 
KO.5(K) and V max for K+ activation, extracellular K+ activation of 86Rb(K+) influxes 
was analyzed with cens equilibrated with monensin and the indicated Na + 
concentration and varying K+ concentrations. The data were fitted to a 
cooperative model (c.f. ref. 13): 
V= Vmax [catt /(K05(cat)+ [catt) (1) 
where "cat" is either Na+ or K+. An average value for the Hill coefficient (n = 
1.3) was used for aIl experiments with varying extracellular K+ since no 
significant difference between n values of control and y-transfected cells was se en 
(1)p>O.l ). Assays were carried out with cells transfected with y (ya and/or yb or 
ybG41R) and control mock-transfected cells. AlI assays were carried out on two 
clones of each type of transfected cell line. Data for the Na+ and K+ activation 
profiles were expressed as percentages ofVmax. 
Determination of lntracellular Cation Concentrations- Cells were grown in 
triplicate to 70-80% confluence on 100 mm tissue culture dishes and washed as 
described previously (18). Following treatment with 3 mL 0.05% Triton X-I00, 
the extract was analyzed for Na+ and K+ content by atomic absorption and for 
53 
protein by the Lowry method. Determinations were carried out on two clones of 
each type of transfected cellline. 
Procedures for varying intracellular ATP and measuring 86Rb(K) influx 
concurrently- To reduce intracellular ATP concentration in a graded and 
reproducible manner, cells cultured in 24-well plates were incubated for 2 h at 
37°C with gentle agitation in medium containing (in mM) 40 NaCl, 2 KCI, 108 
choline chloride, 5 HEPES-Tris, 1.5 P04-Tris, 0.5 MgCh, 1 CaCh, pH 7.4, 1 ~M 
ouabain, 0.1 ~M antimycin A and D-glucose ranging from 0.05-1 mg/mL. The 
medium was aspirated and replaced by the same medium containing 12 ~M 
monensin, 10 ~M bumetanide (to inhibit NaKCl2 cotransport) and 10 ~M ouabain 
(as in flux assays). Following a preincubation of 15 min, one set of triplicate 
wells was taken for the determination of A TP and prote in and a second set was 
taken for the determination of transport activity as described above. For each 
experiment, assays were carried out in triplicate, with either ya-, yb -, or ybG41R-
transfected rat ai-HeLa together with control mock transfected cells assayed 
concurrently. 
Measurement of ATP concentration- Following preincubation as described above, 
the medium from each weIl was aspirated and the cells were immediately chilled 
on ice and lysed with 0.5 mL 5% TCA. Following gentle agitation for 10 min on 
ice, the 24-well plate was centrifuged and the supematant adjusted to pH 7.6 with 
2 M Tris. To each assay vial were added 2.5 mL diluent (in mM: 50 glycine, 1 
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Tris, 5 MgS04, 0.5 EDTA, 0.1% BSA, 0.1% NaN3), 200 J.lL of sample 
supematant or standards (solutions containing 0.001 nmol-1.2 nmol ATP in 5% 
TCA neutralized to pH 7.6), 50 ilL luciferin (357 IlM) and 10 J.lL luciferase (1.5-
3 xl06 units/mL). The light emissions were measured by liquid scintillation 
spectrometry using a wide channel of the single-photon monitor of the Beckman 
Coulter LS 6500 Multi-Purpose liquid scintillation counter. Protein remaining in 
the wells was solubilized with 0.5 mL 0.5 M NaOH and measured by the Lowry 
method. The concentration (mM) of intracellular A TP was estimated by assuming 
8 ilL water/mg protein (18). 
Estimation of intracellular Na + concentration- To estimate intracellular Na + 
concentration in y- and yG41R-cells, we used the following relationship (based on 
ref. Il): 
L. ([Na]out- [Na]in) = Vmax . [Na]in3/( K05(Na) + [Na]ini (2) 
where L is the rate constant of the Na+ leak in S·I, [Na]out and [Na]in represent 
extracellular and intracellular Na + concentrations, respectively, and the other 
parameters have their usual meaning. L was tirst calculated using the kinetic 
parameters of V max and KO.5(Na) of the NalK pump and the measured [Na Jin of the 
control (a1-C) mock-transfected cens. This value of L thus calculated was then 
used to estimate [Na]in in y- and yG41R-transfected cens using values ofVmax of 
the same cens. Since the Na+ concentrations are precisely known in experiments 
carried out with membrane fragments, KO.5(Na) values used were calculated from 
earlier Na + -activation profiles of membrane Na,K-ATPase carried out at high (100 
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mM) K+ concentration (19) using Eq. 1. with n = 3. Iterative techniques using 
Excel software were used to solve the above non-linear Eq. 2. 
Data Analysis- Curve fitting was carried out using the KaleidaGraph computer 
program (Synergy software). Data are presented as mean ± SEM of the number of 
experiments shown in parenthesis. One-way ANOV A, or, where required, a 
nonparametric ANOV A, followed by appropriate pair-wise comparisons were 
carried out with GraphPad Instat software. 
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2.5 RESULTS 
The effect of the two y variants on Na/K pump behaviour of intact cells 
was assessed by comparing the kinetics of Na + and K+ activation of ouabain-
sensitive 86Rb(K+) influx into ya- and yb-transfected al-HeLa cells assayed 
concurrently with control mock-transfected HeLa cells. ybG4lR-transfected al-
HeLa cells were similarly assayed. As described in our earlier studies (18), 
intracellular Na+ was fixed at a range of concentrations by pre incubation with 
monensin. 
Effect of varying Na + 
In the representative experiment depicted in Fig. 2-1, cells were 
equilibrated with varying concentrations of Na + and extracellular K+ 
concentration was kept constant at 4 mM. Figure 2-1 as weil as the results of 
replicate experiments summarized in Table 2-1 show that both y variants decrease 
the apparent affinity for Na+, whereas a difference between ybG4lR and control 
could not be detected. This is consistent with the results of earlier biochemical 
assays of Na,K-ATPase activity using permeabilized membranes. In those 
experiments (19), the precise Na + concentrations were known and the data were 
thus fitted to a 3-site cooperative model (Eq. 1) (see Table 2-2). The differences in 
kinetic constants seen with intact cells (KO.5(Na)app) compared to membranes 
(K0 5(Na» are due presumably to deviations of intracellular Na + from equilibrium 
values, particularly at low concentrations of added Na + (18). V max values of the 
cells used for the determination of [Na]in are shown in Table 2-2. However, the 
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variations between them are not considered meaningful since they probably 
reflect differences in transfection efficiency of the different cDNAs. A key 
question is whether the decrease in apparent affinity for Na+ seen with both y 
variants in intact cells results in an increase in the steady-state intracellular Na+ 
concentration ([Na]in) of the cultured HeLa cells. To address this issue, we 
measured [Na]in in ya- and yb- as weIl as ybG4IR-and mock-transfected rat al-
HeLa cells. The results shown in Table 2-2 indicate that, for aIl y's (ya, yb and 
ybG41 R), the measured [Na Jin values are similar to those calculated from V max of 
the same cells and KOS(Na) obtained from our earlier Na,K-ATPase assays of 
permeable membranes (19) for which Na+ concentrations are known precisely.1 
As evident in equation 2, V max and Kos have opposite effects on [Na Jin. Therefore, 
in yb cells which had a V max similar to the control, [Na Jin is ~ 30% higher than the 
mock control. In contrast, in ya, the higher V max compared to control offsets a 
significant effect ofK05(Na) on [Na]in. 
1 Appropriateness of using K05(Na) from A TPase assays carried out at 100 mM K+ 
is indicated by data showing that KOS(Na) values for at least the two isoforms, al 
and a2, are 16.5 ± 0.1 (Table 2-2) and 21.9 ± 2.25 (A. Zouzoulas and R. Blostein, 
unpublished data), respectively, which are notably similar to K05 (Na) determined in 
flux experiments, i.e. 17.2 ± 1.12 and 19.68 ± 0.96, respectively (values from ref. 
18). 
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Fig. 2-1: Activation of ouabain-sensitive 86Rb(K+) influx by intracellular Na +. 
Ouabain-sensitive 86Rb(K+) influxes were measured in cells equilibrated with the 
indicated concentrations of Na + as described in Experimental Procedures and with 
4 mM extracellular K+. Data are expressed as percentages of V max calculated as 
described in Experimental Procedures. In the representative experiment shown, 
KO.5(Na)app (mM) was determined as described in Experimental Procedures. Values 
for control- (0), ya- (0) and yb- (<» transfected cells were 8.9, 18.9 and 18.7, 
respectively. 
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Table 2-1: Effects of Y on apparent cation affinities 
a1-C a1-ya al-yb a1-ybG41R 
K0 5(Na)app 8.7 ± 0.4 14.9 ± 1.2*** 17.2 ± 0.8***t 8.0 ± 0.5* 
(mM) (24) (12) (14) (6) 
aK05(K) 0.62 ± 0.02 0.40 ± 0.02*** 0.40 ± 0.02*** 0.58 ± 0.01 * 
(mM) (14) (7) (7) (3) 
Numbers in brackets indicate the number of separate experiments. V max values 
are shown in Table 2-2. 
aK05(K) was determined with cells equilibrated with 20 mM Na+ as described in 
Experimental Procedures. 
***p< 0.001 compared to control, *p > 0.05 compared to control, tp> 0.05 
compared to ya 
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Table 2-2: Effect of yon steady-state parameters of Na + transport 
Transfected [Na] in [Na] in 
al-HeLa aKO.5(Na) Vmax (measured) ( calculated) 
cells 
(mM) (nmoles/mg/min) (mM) (mM) 
mock 16.5 ± 0.1 37.8 ± 0.9 (24) 10.4 ± 0.6 (11) - -
ya 20.7 ± 0.3*** 42.2 ± 1.9* (12) 11.7 ± 0.6* (9) 12.2 
yb 21.9 ± 0.5***§ 36.5 ± 1.7* (14) 14.5 ± 0.5***t (7) 13.9 
yb-G41R 16.2 ± 0.3* 30.7 ± 0.8** (6) 10.7 ± 0.6* (7) Il.4 
Numbers in parentheses refer to the number of separate [Na]in (each in triplicate) 
and Vmax determinations. The measured value of [Na]in for mock cells was 10.4 
mM and this value was used to calculate the leak constant needed for estimation 
of intracellular Na + concentration (see Experimental Procedures and equation 2). 
acalculated from data obtained by Pu et al. (19) using equation 1 and n = 3, and 
are based on assays carried out at 100 mM K+. 
***p< 0.001 compared to control, ** p< 0.01 compared to control, *p > 0.05 
compared to control, §p> 0.05 compared to ya, tp < 0.05 compared to ya 
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Effect of varying extracellular r concentration 
In previous studies using unsided membrane fragments, we failed to detect 
a significant effect of y on K+ -activation kinetics of Na,K-A TPase of rat a 1-
transfected HeLa cells (ref. 19 and experiments not shown). In contrast, 
Arystarkhova et al. (1) reported a y-mediated decrease in K+ affinity in their 
experiments with y-transfected NRK52E cells. Similarly, treatment of rat renal 
membranes (al3y pumps) with anti-y (C-terminal) antibodies increased K'K (25). 
In the latter study, the increase in K'K diminished with increase in ATP 
concentration, consistent with the consecutive model of A TP-accelerated K+ 
deocclusion following K+-activated dephosphorylation ofE2P (c.f. ref. 7) whereby 
an increase in A TP affinity should decrease apparent K+ affinity and vice versa. 
Although a statistically significant effect of y on K05(K) was not detected in our 
initial flux studies with intact cells (19), this issue was addressed further by 
performing a large number of experiments with cells equilibrated with Na + at 
various concentrations. The results of these flux studies comprising control 
versus ya and yb assayed concurrently (summarized in Table 2-1; typical 
experiment shown in Fig. 2-2) indicate that both variants cause a modest but 
significant increase in apparent affinity for K+. Similar percentage decreases (= 
30%) in K05(K) were observed over a range ofNa+ concentrations tested as shown 
in Table 2-3. As in the experiments carried out at 20 mM Na+ and shown in Table 
2-1, a difference between the effects of ya and yb was not detected. 
63 
Fig. 2-2: Activation of oua bain-sensitive 86Rb(~) influx by extracellular ~. 
Ouabain-sensitive 86Rb(K+) influx was carried out as described in Experimental 
Procedures. Data are expressed as percentages of V max. In the representative 
experiment shown, the cells were equilibrated with 20 mM Na+. KO.5(K) (mM) for 
control- (0), ya- (0) and yb- (<» transfected cells were 0.51, 0.35 and 0.38, 
respectively. 
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Table 2-3: Effects of Y on KO.S(K) as a function ofvarying extracellular Na + 
K05(K) (mM) 
Na+ (mM) mock ya and yb 
10 0.34 ± 0.03 (4) 0.25 ± 0.02** 
a20 0.62 ± 0.02 (14) 0040 ± 0.01 ** 
40 1.01 ±O.l2 (7) 0.73 ± 0.04* 
80 2.90 ± 0.02 (3) 1.87 ± 0.05** 
Numbers in brackets indicate the number of separate experiments. 
a Data taken from Table 2-1 
** p < 0.01, *p< 0.05 compared to control (unpaired t-test) 
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(7) 
(14) 
(6) 
(4) 
Does yaffect the A TP-dependence ofNa/Kpump activity? 
To determine whether the y-mediated increase in A TP affinity seen In 
biochemical Na,K-ATPase assays carried out with fragmented membranes is 
evident in intact cells, the relationship between pump flux and cellular A TP 
concentration was compared in y-transfected and mock-transfected HeLa cells. In 
preliminary experiments, we used various strategies to deplete intracellular A TP 
and found that preincubation of cells with antimycin A and varying the 
concentration of glucose prior to the transport assay provided an optimal means of 
varying intracellular ATP in a graded fashion. Fig. 2-3 depicts a typical range of 
intracellular A TP concentrations obtained following a 2 h depletion. The data 
show similar depletion patterns for control and y cells. It was shown previously 
(12) that incubation of HeLa cells with metabolic inhibitors causes the cells to 
gain Na + to different extents depending on the intracellular A TP content. To avoid 
changes in [Na]in as the ATP is altered, cells were equilibrated with monensin and 
40 mM Na + after ATP depletion as described in Experimental Procedures. Figure 
2-4A shows a representative experiment in which pump activity was measured in 
mock- and yb-transfected cells with varying A TP concentration. In ail 
experiments, the flux showed no saturation up to the highest A TP concentration 
measured. In each paired experiment, the slope of the relationship between flux 
and ATP concentration was greater for y- compared to mock-transfected cells. 
Thus, for 8 paired experiments (3 with ya- and 5 with yb- versus the mock-
transfected control cells) a mode st 22.7 ± 4.5% increase in pump rate as a function 
of A TP concentration in y-transfected compared to control mock-transfected cells 
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was seen. When ybG41R-transfected and mock-transfected cells were compared 
(2 experiments), a difference was not detected (representative experiment shown 
in Fig. 2-4B), which is consistent with results that this mutant lacks any of the 
functional effects ofwild-type y (20), thus behaving like mock-transfected cells. 
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Fig. 2-3: ATP concentration in cells varied by incubation for 2 hours with 
antimycin A and varying concentrations of glucose. See Experimental 
Procedures. Values for control- (0), y- (0). 
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Fig. 2-4: Effect of ATP depletion on ouabain-sensitive 86Rb(K1 influx. 
Following ATP depletion, 86Rb(K+) influx was measured as described in 
Experimental Procedures. (A) Representative experiment of control- (0) vs yb-
(-) transfected al-HeLa cells. (B) Representative experiment of control-CO) vs 
ybG41R- (0) transfected al-HeLa cells. 
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2.6 DISCUSSION 
The present study with intact cells confirms our earlier conclusion from 
experiments with membrane fragments (Na,K-ATPase assays; see ref. 19), that 
both variants of the y modulator of the sodium pump lower the apparent affinity 
for Na+. We showed further that the y-mediated decrease in apparent Na+ affinity 
is secondary to an increase in K+ affinity at intracellular Na + -activation sites 
(K+ /Na + antagonism) (23). Thus, an earlier extensive kinetic analysis showed that 
a y-mediated decrease in apparent Na + affinity seen at high K+ concentrations is 
due to a higher apparent affinity for K+ as an antagonist at Na+ activation sites 
rather than a difference in Na + affinity per se. Consistent with those experiments, 
the y-mediated increase in K05(Na)app is se en here in intact cells in which the 
intracellular K+ /Na + ratio is high. A similar result was reported by Garty et al. (9), 
although the variant analyzed was not specified. The present study also shows that 
the lowered apparent affinity for Na+ is associated with an ~ 30% increase in the 
steady-state Na + content of our cultured yb-transfected HeLa ce Ils (Table 2-2). 
Despite the similar increase in KO.S(Na)app seen with both y variants, a significant 
increase in [Na lin is not seen in our ya clones; presumably the effect of a higher 
K05(Na) on [Na lin of those cells is offset by their higher V max. It is noteworthy that 
in both variants, [Na lin values agree with those predicted from the relationship 
between K05(Na) and V max values assuming that aIl cells have the same leak 
constant as control mock-transfected cells (see Eq. 2). 
The y-stimulated increase (~ 20%) in pump flux as a function of varying 
intracellular A TP concentration is notably lower than the increase (~ 50%) in A TP 
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affinity observed in membrane Na,K-ATPase assays (20). This discrepancy 
probably reflects the two distinct and opposite effects of y on apparent Na + and 
ATP affinities. Thus, if one takes into account the lower apparent Na+ affinity 
caused by y as depicted in Fig. 2-1 and Table 2-1, an ~ 18% decrease in flux rate 
due to the change in KO.5(Na)app is predicted under the condition used in Fig. 2-4A 
(cells equilibrated with 40 mM Na+). Therefore, the expected y-mediated increase 
in flux over the range of ATP concentrations of the experiments in Fig. 2-4A 
should be reduced from 50% (due to the effect on K' ATP) to 23% (due to the 
additional effect on K05(Na)app; Fig. 2-1), which is similar to that observed (22.7 ± 
4.5%; see Results). lt is also clear that the y modulator decreases the apparent 
affinity for Na+ at high K+ in both cells (this study) and membranes (19, 20), 
without a significant difference in the effect of ya versus yb. However, the 
absolute values of KOS(Na)app and KO.5(Na) (Na,KA TPase assays) cannot be 
quantitatively compared since, despite the presence of monensin, chemical 
equilibrium is not attained. The physiological relevance of these opposing effects 
of y is discussed below. 
Na,K-ATPase assays of isolated membrane preparations measured as a 
function of A TP concentration indicate that the Na/K pump has a Kos for ATP of 
approximately 400 /lM, whereas experiments with intact cells reveal that the 
ouabain-sensitive flux does not appear to saturate with A TP up to at least 2 mM. 
The near linear relationship between 86Rb(K+) influx and A TP seen in this study is 
consistent with previous results obtained with HeLa cells (12). This behaviour is 
also reminiscent of the findings with intact renal tubules in which a linear 
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dependence of the NalK pump on A TP up to about 3 mM was observed (21). As 
these authors point out, the products of A TP hydrolysis inhibit the forward pump 
reaction. Thus, increased formation of products, particularly ADP, as ATP is 
lowered would inhibit the pump, thereby linearizing the normally hyperbolic 
curve relating flux to A TP concentration. 
OveraIl, the increase in flux as a function of A TP concentration as weIl as 
the increase in steady-state intracellular Na+ concentration are relatively mode st. 
Nevertheless, considering the major role of the pump in salt and water balance 
and as we have discussed elsewhere (27, 28), the y modulator may serve to 
maintain pump activity under energy-deprived conditions su ch as may occur in 
the anoxic mTAL. At the same time, by lowering apparent Na+ affinity, an 
appropriate intracellular Na+ level for Na+-coupled transport processes is 
maintained. 
The increase in apparent K+ affinity of Na/K pumps seen in the present 
study with intact cells was not seen in experiments with permeable membrane 
preparations (19). We considered the possibility that this difference is a 
consequence of the high intracellular K+ INa + concentration ratio of intact cells 
since we showed previously that the y modulator increases the apparent affinity 
for K+ as an antagonist of cytoplasmic Na+ activation (19, 23). Accordingly, y 
may increase the backward rate of the E2(K) ~ -----). EJ+ K\yt reaction step and 
thus increase the apparent affinity for extracellular K+ in the preceeding E2P+K+ext 
-----). E2(K) + Pi step. This is an unlikely explanation since the y-mediated decrease 
in KO.5(K) was similar in cells equilibrated over a range of Na + concentrations (see 
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Table 2-3) and hence changing intracellular K+/Na+ ratios. Altematively, it is 
notable that in experiments with oocytes, the apparent affinity for extracellular K+ 
was increased by both y variants provided that the membrane potential was 
clamped at values more negative than ~ -50 m V (4, 15). Therefore it is plausible 
that in HeLa cells as in oocytes, there is a membrane potential-sensitive y-
mediated increase in the intrinsic affinity of the pump for extracellular K+. 
What is the physiological significance of the increase in apparent K+ 
affinity caused by y se en in experiments with intact cells? Under physiological 
conditions the normal serum K+ concentration ranges from 3.7 to 5.2 mM and 
thus, extracellular K+ activation sites would not be completely saturated, 
particularly in cells without y. Thus, at the highest concentration ofNa+ tested (80 
mM), KO.5(K) values were 2.90 mM and 1.87 mM for control and y-transfected 
cells, respectively (see Table 2-3). These values would be ev en higher at 
physiological concentrations (~ 140 mM) of extracellular Na+ due to the well-
documented Na + /K+ competition at extracellular K+ -activation sites (3). 
Accordingly, the increase in apparent affinity caused by y is another means of 
maintaining pump activity under energy-compromised conditions. 
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CHAPTER3 
Structure/function analysis of the transmembrane segment of y 
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3.1 PREFACE 
This manuscript has been published in the Journal of Biological Chemistry and is 
titled "Modulation of Na,K-ATPase by the y subunit: studies with transfected 
cells and transmembrane mimetic peptides" (Zouzoulas, A., Therien, A.G., 
Scanzano, R., Deber, C.M., and Blostein, R. J. Biol. Chem. 278, 40437-40441, 
2003). Its aim was to gain insight into (i) regions of the TM helix that are 
important for trafficking and/or association with aJ3 pumps, (ii) the structural 
basis for the increase in K'Na effected by y. 
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3.2 ABSTRACT 
The enzymatic activity of the Na,K-ATPase, or sodium pump, is 
modulated by members of the so-called FXYD family of transmembrane proteins. 
The best characterized member, FXYD2, also referred to as the y subunit, has 
been shown to decrease the apparent Na + affinity and increase the apparent A TP 
affinity of the pump. The effect on A TP affinity had been ascribed to the 
cytoplasmic C-terminal end of the prote in, whereas recent observations suggest 
that the transmembrane (TM) segment of y mediates the Na + affinity effect. Here 
we use a novel approach involving synthetic transmembrane mimetic peptides to 
demonstrate unequivocally that the TM domain of y effects the shift in apparent 
Na+ affinity. Specifically, we show that incubation of these peptides with 
membranes containing cx(3 pumps modulates Na+ affinity in a manner similar to 
transfected full-Iength y subunit. Using mutated y peptides and transfected 
proteins, we also show that a specific glycine residue, Gly-41, which is associated 
with a form of familial renal hypomagnesemia when mutated to Arg, is important 
for this kinetic effect, whereas Gly-35, located on an altemate face of the 
transmembrane helix, is not. The peptide approach allows for the analysis of 
mutants that fail to be expressed in a transfected system. 
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3.3 INTRODUCTION 
The Na,K-ATPase or sodium pump is an integral membrane protein found 
in the cells of virtually ail higher eukaryotes and is one of the most important 
systems involved in cellular energy transduction (8, 19). It catalyzes the 
electrogenic exchange of three intracellular Na + for two extracellular K+ ions 
energized by the hydrolysis of one molecule of A TP. The transporter plays a 
major role in ion homeostasis, and, in epithelia, the sodium gradient created by 
the pump also plays an important role in secondary active transport mechanisms 
that are necessary for Na + -dependent reabsorption of a variety of solutes including 
sugars and amino acids. 
There is an increasing body of evidence that members of a family of 
membrane proteins, the so-called FXYD family (21), associate with and modulate 
the kinetic behaviour of the sodium pump (for a recent overview, see ref. 3). 
Members of this family of proteins are small, single transmembrane (TM) 
proteins characterized by an N-terminal PFXYD motif that remains invariant in 
ail mammals. There are at least seven known family members, of which several 
appear to modulate the kinetic behaviour of the pump in a tissue-specifie manner 
(1, 2, 12, 25). To date, the y "subunit" of the renal Na,K-ATPase is the best 
characterized member (reviewed in refs. 23 and 28). Gamma, or FXYD 2, exists 
as two main splice variants, ya and yb, with distinct as weIl as overlapping 
localization along the nephron (16). Mass spectrometry of ya and yb indicate that 
they differ only in the N terminus; in rat ya, TELSANH is replaced by Ac-
MDR WYL in yb (9). Previous studies using membrane fragments isolated from y-
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transfected rat al-HeLa cens have shown that y serves at least two distinct 
functions in regulating the pump, and the effects are similar for both variants (16, 
26). These distinct effects of y include the following: (i) an increase in the 
apparent affinity for A TP; and (ii) an increase in K+ /Na + competition at 
cytoplasmic Na+ activation sites, as seen by an increase in K'Na at high [K+]. 
Previous studies have suggested that the effect on A TP affinity is mediated by the 
cytoplasmic C-terminal domain of the prote in (17, 25), whereas effects on K+ /Na + 
antagonism may be associated with the TM domain (10). 
In this study, we have used a novel strategy to assess directly the 
functional effects of the TM region of FXYD 2 whereby peptides corresponding 
to the TM domain of y are added directly to membranes derived from cens devoid 
of the prote in. In addition, we describe a mutagenesis approach to 
structure/function analysis of y using both transfected cells and peptides. A 
residue ofparticular interest is Gly-41, because it is replaced by Arg (G4IR) in a 
familial form of renal magne sium wasting (13) and is invariant throughout the 
FXYD family. The other residue examinedis Gly-35 because ofits location at the 
altemate face of the membrane relative to Gly-41 (24). Effects of peptides with 
either of these Gly residues replaced by Arg or Leu are compared with those of 
the full-Iength transfected y proteins (wild-type or mutants of the yb variant) 
expressed in cultured rat al-transfected HeLa cens. This approach allows for 
assessment of the role of the TM region alone and provides an opportunity to 
distinguish the effects of mutations on biogenesis and routing to the plasma 
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membrane from the direct effects on association and kinetic modulation of al3 
pumps. 
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3.4 EXPERIMENTAL PROCEDURES 
Mutagenesis, Transfection, Tissue Culture, and Membrane Preparations- Point 
mutations were introduced into yb cDNA subcIoned into the pIRES expression 
vector and then transfected into HeLa cells stably expressing the rat al subunit of 
the Na,K-ATPase (al HeLa cells were kindly provided by Dr. J. B. Lingrel) as 
described previously (17). Unless indicated otherwise, cellular membranes from 
the stably transfected cells were prepared as described by Jewell and Lingrel (7). 
Polyacrylamide Gel Electrophoresis and Western Blotting- SDS-PAGE and 
Western blotting were carried out as described previously (16), and, following 
transfer to polyvinylidene difluoride membranes, the lower half was analyzed 
with a polycIonal y antibody (yC32 raised against the C-terminal KHRQVNEDEL 
peptide and essentially the same as yC33 described previously in ref. 27), and the 
upper halfwas analyzed with anti-al subunit A277 (Sigma). 
Coimmunoprecipitation- The method used is a modification of Garty et al. (5). 
Briefly, 250 ~g of membranes, prepared from ybWT- and ybmutant-transfected cells 
as described previously (7), were resuspended and incubated at room temperature 
for 30 min in immunoprecipitation buffer containing 50 mM imidazole, pH 7.5, 1 
mM EDTA, 10 mM RbCI, and 5 mM ouabain in a final volume of 250 ~l. 
Polyoxyethylene 10 lauryl ether (CI2EIO) (250 ~l of a 2 mg/ml solution in water) 
was then added (final concentration, 1 mg/ml), and the suspension was incubated 
for 30 min at 4 oC with end to-end rotation. Following centrifugation at 4°C for 
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30 min at 16,000 x g, the supernatant was added to 50 ,.tI of bovine serum albumin 
(1 mg/ml)-treated prote in A Sepharose beads and incubated for 30 min at 4°C, 
and the beads were then centrifuged to remove non-specifically bound proteins. 
The supernatant was removed and a 10-,.d aliquot was taken for SDS-PAGE. To 
another 450-J-l1 aliquot, 90 J-li of RbCI (118 mM final concentration) and 30 J-li of 
yC32 anti-serum (stored at -20°C in 50% glycerol) were added, and the 
suspension was further incubated for 4 h at 4°C with end-to-end rotation. The 
suspensIOn was then mixed with protein .. A-Sepharose beads (100 J-ll) and 
incubated overnight at 4°C. Beads were washed SIX times with 
immunoprecipitation buffer without ouabain, and the immunoprecipitated proteins 
retained by the beads were eluted with 100 J-li of SDS-PAGE sample buffer 
containing 5% [3-mercaptoethanol at 37°C for 30 min. A 20-J-l1 aliquot of the 
eluate and the 10-J-l1 sample removed before addition of antiserum were resolved 
by SDS-PAGE followed by Western blotting. 
Cel! Surface Biotinylation- Transfected al-HeLa cells were grown to =80% 
confluence in 6-well plates. The surface biotinylation is a modification of Stephan 
et al. (20). Briefly, the cell surface biotinylation reaction was carried out on ice 
for one 20-min period using sulfosuccinimidyl-2-(biotinamido )ethyl-l ,3-
dithiopropionate (sulfo-NHS-SS-biotin) (Pierce). After biotinylation, each weIl 
was rinsed briefly twice with a phosphate-buffered saline (PBS), 0.1 mM CaCh 
and 1 mM MgCh (CM) solution containing 100 mM glycine and then treated with 
the same solution for 30 min to ensure complete quenching of unreacted sulfo-
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NHS-SS-biotin. The cells were then lysed for 45 min with 500 !lI of LI buffer 
(1% Triton X-IOO/O.l% SDS in 150 mM NaCI, 5 mM EDTA, and 50 mM Tris-
HCI, pH 7.5, containing 10 !lg/ml each leupeptin and pepstatin and 200 !lM 
phenylmethylsulfonyl fluoride). Each well was then scraped, and the sample was 
collected and centrifuged at 18,000 x g for 10 min. One 20-!l1 aliquot of 
supernatant (total fraction, 1) was taken for prote in determination (Lowry 
method) and another (5 !lI), for Western blotting. The biotinylated surface-
exposed proteins were isolated by incubating a 150-!lg (=85 !ll) fraction in L2 
buffer (L 1 buffer without SDS; final volume, 500 !ll) with 100 !lI of streptavidin-
agarose beads (Pierce) overnight at 4°C with gentle rotation. The samples were 
then centrifuged to separate beads and supernatant (unbound fraction, U), and an 
aliquot of U (15 !lI = 2.5 !lI of 1) was taken for Western blotting. The beads were 
washed three times with L2 buffer, twice with high salt L2 buffer (L2 buffer with 
500 mM NaCI and 0.1% Triton X-I00), and then once with 50 mM Tris-HCl, pH 
7.5. The biotinylated proteins were eluted from the beads (Fraction B) by 
incubation in 100 !lI of SDS-PAGE sample buffer containing 5% 13-
mercaptoethanol at 85°C for 10 min and an aliquot (30 !lI = 25 !lI of 1) was taken 
for Western blotting. 
Peptide Synthesis- Synthetic peptides corresponding to residues 23-48 of the TM 
segment of wild-type yb, mutant TM peptides with replacements G41R, G41L, 
G35R, G35L, and the scrambled peptide, all containing three lysine residues on 
the N- and C- termini to aid in synthesis and purification, were prepared as 
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described previously (14, 24). The sequences ofthese peptides are shown in Fig. 
3-1. 
Kinetic Assays and Data Analysis- Kinetic assays of Na,K-A TPase were carried 
out in triplicate as described previously (16) using membranes isolated from 
mock-transfected and either mutant or WT yb transfected rat al-HeLa cells. For 
studies of the kinetic effects of the various peptides, the permeabilized 
membranes were incubated in buffered medium (15 mM Tris-HCl, pH 7.4 
containing 1 mM EDTA) with peptide such that the peptide concentration was 
16.7 /lM (3.3 /lM in the final assay mixture) and the membrane protein 
concentration was 0.15-0.2 mg/ml. Following incubation for 10 min at room 
tempe rature and then for 1 h on ice, the membranes were preincubated for 10 min 
at 37°C with 5 /lM ouabain and assayed for Na,K-A TPase activity with the data 
analyzed as described previously (16). 
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Fig. 3-1: Amino acid sequences oftransmembrane mimetic peptides. 
TM Pe tides 
yWT 
yG41R 
yG41L 
yG35R 
yG35L 
Serambled 
Se uenees 
KKKTVRKGGLIF AGLAFVVGLLILLSKRFKKK 
--------------------------------------R----------------------
--------------------------------------L----------------------
--------------------------R----------------------------------
--------------------------L----------------------------------
KKKGLRKLLGL TVRIFVLAIFSGVFLKRAKKK 
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3.5 RESULTS 
Studies with Transfected Cells 
Several approaches were used to gain insight into the role of two glycine 
residues, Gly-41 and Gly-35, on y processing, trafficking, and association with the 
Na,K-ATPase on the one hand and the functional effect on K+/Na+ antagonism on 
the other. 
To assess y association with the catalytic a subunit and y surface 
expression, we tested a/y coimmunoprecipitation and cell surface biotinylation 
followed by streptavidin bead isolation and Western blotting of a and y, 
respectively (see ref. 17). The coimmunoprecipitation experiment (Fig. 3-2A) 
shows that yb and yb-G35L associate with a, whereas yb-G41L shows weak 
association, and yb-G41R and yb-G35R show litde, if any, association. In 
addition al experiments (not shown), a/y association se en at lower detergent 
concentration (0.4 mg/ml) is increased for yb-G41L but not for yb-G41R. The 
surface biotinylation results (Fig. 3-2B) show that yb and yb-G35L and, to sorne 
extent, the yb-G41L mutant, traffic to the surface. As shown earlier (26), little if 
any yb-G41R appears at the surface. Although the low expression of yb-G35R 
precluded assessment of its surface expression, these results indicate that the 
appearance of the WT and mutant y chains at the cell surface parallels their ability 
to associate with a. A surprising finding is the low level ofyb-G41L relative to a 
in the Triton X-IOO-solubilized cells (total fraction, Fig. 3-2B) compared with the 
relative amounts seen in Western blots of total membranes that were not subjected 
to this detergent treatment (see Fig. 3-2A). The reason for this apparent 
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discrepancy is under investigation, although this observation does not detract from 
the conclusion that this mutant does, in fact, traffic to the cell surface. 
Further evidence for altered y trafficking in the Gly ~ Arg mutants is the 
failure to detect post-translational modification of y. Thus, in Western blots of 
multiple clones of rat al-HeLa cells transfected with WT yb and each of the 
above-mentioned mutants (experiments not shown), the yb chain appeared as a 
doublet (yb and yb'; cf ref. 16) in WT yb and the conservative mutants ybG4lL 
and ybG35L but not in the ybG41R and ybG35R mutants. We then looked at the 
functional properties of the various yb transfected cells. Table 3-1 summarizes 
measurements of apparent Na+ affinity of Na,K-ATPase measured at high K+ 
concentration (100 mM) of membranes isolated from the mock-transfected 
(control) as weIl as the WT and mutant yb-transfected cells. The results indicate 
that yb-G35L behaves like WT y in that it decreases the apparent affinity for Na+; 
K'Na is increased 2.5-fold by yb-G35L and nearly 2-fold by yb. In contrast, yb-
G4IL, like yb-G4IR, does not increase K'Na. Unfortunately, yb-G35R mutants 
were expressed at levels too low for meaningful kinetic analysis. 
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Fig. 3-2: Effect of y-TM mutations on a.-y association and cell surface 
expression of a. and y. A, membranes were solubilized and immunoprecipitated 
with yC32 as described under "Experimental Procedures." Aliquots of the total 
solubilized prote in (PreIP) and the immunoprecipitate (IP) were resolved by 
SOS-PAGE and analyzed by Western blotting using anti-yC32. As described, the 
aliquots of PreIP and IP represent 5 and 45 Ilg, respectively, of the original 
membrane protein. B, cell surface biotinylation was carried out as described under 
"Experimental Procedures." For the unbound (U) anq bound (B) fractions, the 
amounts analyzed by Western blot analysis were 0.5 and 5 times the amounts of 
the total fraction (1) analyzed, respectively. For the biotiny lation analysis in panel 
B, the amount of material analyzed with respect to the original cell number was 
=1/100th that used in the coimmunoprecipitation analysis shown in panel A; for 
chemiluminescent detection, the time of exposure of the polyvinyl difluoride 
membrane to x-ray film was 60-120 times greater in panel B compared with 
panel A. *, expression of yb-G35R was very low as shown by the PreIP (A) and 
the T fraction (B). 
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A 
Immunopreci pi tation 
Pre-IP IP 
yb 
ybG41R 
ybG41L 
ybG35R* 
ybG35L 
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B 
Surface biotinyla1 
a .. 
y .. 
TUB 
Effects ofTransmembrane Mimetic Peptides 
Studies of the effects of peptides comprising the TM sequence of y (y-
TM), G41R (yG41 R-TM) , G41L (yG41L-TM), G35R (yG35R-TM), and G35L 
(yG35L-TM) Y as weIl as a "scrambled" peptide ("yS cr-TM") were carried out 
with synthetic peptides containing "lysine tags" at both the N- and the C- termini. 
These tags overcome the inherent insolubility of these y-helical TM peptides, thus 
aiding in their synthesis and purification, but retain their native TM oligomeric 
states (14, 24). Fig. 3-3 shows the Na+ activation profile measured at high (100 
mM) K+ concentration without and with the various TM peptides. Compared with 
y-Scr-TM, the addition of either y-TM or yG3 5L-TM peptide to y-devoid 
membranes isolated from rat al-HeLa cells increases K'Na. The increase effected 
by G35L is ev en greater than se en with the WT peptide, similar to the greater 
effect of ybG35L compared with yb in y-expressing ceIls (described above). In 
contrast, yG41R-TM, yG41L-TM, and yG35R-TM did not increase K'Na above 
that observed with the control scrambled peptide (yScr-TM). A nonspecific effect 
of peptide addition is evident in a small but consistent increase in K'Na seen 
irrespective ofwhether yScr-TM or any of the three mutants, yG35R-TM, yG41R-
TM and yG41L-TM, is added. The other notable kinetic effect of the full-Iength y 
chain, the decrease in K' ATP, was not seen with y-TM (experiments not shown), 
consistent with earlier evidence (17) that this effect is mediated primarily by the 
cytoplasmic C-terminus. 
We showed previously that K'Na is a linear function of K+ concentration, 
approximating a simple competitive model of cytoplasmic K+ /Na + competition, 
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i.e. K'Na = KNa (1 + (K+]IKK) (4, 18,27), and that the main effect of either ya or yb 
was not due to an increase in KNa, but rather to a decrease in KK. To further assess 
the specificity of the mimicry of the TM peptides, we determined K'Na as a 
function of K+ concentration and, thus, values of KNa (K'Na when [K+] = 0) and 
KK (the apparent K+ affinity for competition with cytoplasmic Na+). The results 
shown in the inset to Fig. 3-3 support the conclusion that y-TM and yG35L-TM 
peptides, like their full-Iength counterparts (see table in ref. 16), decrease KK with 
little effect on KNa. 
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Fig. 3-3: Effect of TM peptides on apparent Na + affinity determined at 100 
mM K+. Na,K-ATPase assays were carried out as described (16) with or without 
preincubation in the presence of various TM peptides as described in 
"Experimental Procedures." Data points are presented as percentages of the 
maximal activity observed in separate experiments in which the Na + concentration 
was increased to 200 mM (total chloride concentration, 300 mM). Values of K' Na 
determined at 100 mM K+ (mean ± S.E. of the number of replicate experiments 
shown in brackets) following addition of WT, G41R, G41L, G35R, G35L, and 
Scr peptides were 15.41 ± 0.80 (18), 8.79 ± 0.33 (6), 7.01 ± 0.97 (3), 8.65 ± 0.58 
(6),21.56 ± 2.45 (4), and 8.35 ± 0.39 (3), respectively, and, in the absence of an 
added peptide, 4.78 ± 0.18 (10). Inset, KNa, and KK were estimated from values of 
K'Na determined at various concentrations ofK+ using the relationship K'Na = KNa 
(1 + [K+]IKK), where (KNa = K'Na at [K+] = 0) (4). 
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Table 3-1: Summary of comparative effects of Ywt and Ymutants on apparent 
affinity for Na+ at 100 mM K+. 
Membranes 
Control (mock) 
yba 
ybG41R 
ybG41L 
ybG35R 
ybG35La 
K'Na at 100 mM K+ 
4.8 ± 0.2 
8.3 ± 0.4 
5.3 ± 0.2 
4.5 ± 0.02 
n.d.b 
1O.7± 0.8 
ap < 0.01 for yb and ybG35L compared ta control membranes. 
bn.d., not determined due to low expression 
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As shown in Fig. 3-4, in control experiments carried out with the y-TM 
peptide and/or the yG35L-TM peptide, an increase in K'Na seen with mock-
transfected cell membranes is seen also with ybG41R-transfected but not yb-
transfected membranes. Thus, the kinetic effects of the mimetic peptides are 
highly specific in that they are seen only with pumps not already associated (mock 
transfected) or minimally associated (yb-G4IR) with full length y chains. As 
expected, yG41L-TM and yG41R-TM peptides had no effect on the K'Na values of 
pumps in any of the transfected systems. 
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Fig. 3-4: Effect of TM peptides on membranes isolated from yb and ybG4lR 
transfected rat a.l-HeLa cells. K'Na values were determined as in Fig. 3-3. 
Activity with TM peptides added to either al-HeLa (control), yb-aI-HeLa, or 
ybG41R-al-HeLa membranes are presented as the fold change in K'Na compared 
with membranes with no peptide added, normalized to 1.0. Error bars are S.E. of 
at Ieast three experiments. In the absence of added peptide, values of K'Na were 
4.8, 8.3, and 5.3 mM for control, yb, and ybG41R membranes, respectively (see 
Table 3-1). Data for control membranes are taken from Fig. 3-3. 
105 
~ no peptide 
Il WT 
o G41R 
D G41L 
~ G35R 
5 ~ G35L III Scr 
l'I:J 
z 
s.r: 4 C 
.-
C» 
= C» .. 3 () 
C 
.-
" -0 
LI. 2 
1 
control yp ypG41R 
Membranes 
106 
3.6 DISCUSSION 
The experiments described herein unequivocally show that the effect of y 
(FXYD 2) on the K'Na values of Na,K-ATPase is mediated solely by the TM 
domain of the protein, as suggested recently (10). Thus, peptides comprising only 
this region of y simulate functional effects obtained in assays performed on 
membranes isolated from wild-type and mutant yb-transfected al-HeLa cells. The 
mimetic effects of the peptides underscore the feasibility of using TM peptides to 
evaluate kinetic effects of TM helices, including instances in which adequate 
expression is problematic, as is the case of the yb-G35R mutant. TM mimetic 
peptides offer the unique advantage of examining the function of the TM domain 
without the complexity of long range effects of extramembranous regions. In fact, 
concem over this complexity was mentioned by Lindzen et al. (10) who raised the 
possibility that a change in K' ATP effected by the cytoplasmic do main may mask 
an apparent effect of y-TM on K+/Na+ antagonism, which may account for the 
larger decrease in KK effected by y-TM and yG35L-TM compared with the 
analogous transfectants (compare inset of Fig. 3-3 with Table 3-1). 
The results of the present study provide insight into the role of two Gly 
residues, Gly-35 and Gly-41, which reside on opposite faces of the helical TM 
domain of y. The observation that both the yb-G35R (Fig. 3-1) and yb-G4l R (16) 
mutants show either minimal expression or processing and trafficking led us to 
consider more conservative mutations in our attempts to understand the role of 
these residues in modulating pump function. We therefore studied G35L and 
G4l L mutants in experiments with both transfected cells and synthesized 
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peptides. These mutants circumvent the energetic cost associated with inserting a 
positively charged residue within the hydrophobic core of the membrane and are 
therefore more relevant in studying the role of the native glycine residues. This 
consideration may not only explain the low processing/trafficking of Arg mutants 
but also the lack of effect of the y035R-TM peptide on sodium pump kinetics 
(Fig. 3-3). 
The studies with both transfected cells and peptides provide evidence that 
disruption of a Gly residue (Gly-41) on one face of the y helix but not on the other 
(Gly-35) abrogates the increased K+/Na+ antagonism effected by y as seen by a 
notable increase in K'Na at a high K+ concentration. Thus, the abolition of the 
kinetic effect is seen not only with the disrupting mutation 041R replacement 
associated with autosomal dominant renal magnesium wasting (13) but also with 
the conservative mutation, 041 L. Previous results from our laboratory (17) 
suggested that Gly at position 41 is essential for normal trafficking to the cell 
surface and association with the pump. However, even when the cellular 
processing and trafficking problems are circumvented, as is the case with the 
041 L mutant and the peptide experiments presented herein, mutating this residue 
fails to increase K' Na above levels seen with a control scrambled peptide. 
Importantly, yb041L appears to be expressed at the surface (Fig. 3-2B) and to 
associate, at least to an extent, with the a subunit (Fig. 3-2A), confirming a role 
for Gly-41 in mediating one of the kinetic effects of y but not primarily in al3-y 
association. Such a dissociation between residues important for the functional 
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effects of y and its interaction with the sodium pump IS consistent with the 
findings of Lindzen et al. (10). 
In contrast to Gly-41, Gly-35 on the opposite face of the helix does not 
appear to be functionally important, because the G35L mutation does not abrogate 
kinetic function. Our results also suggest that Gly-35 is not involved in 
association of y with the a~ complex, because yb-G35L was able to co-
immunoprecipitate with the a subunit (Fig. 3-2A). The latter finding is consistent 
with recent experiments showing that the residues important for this association 
are on a different side of the helix (see Fig. 5 in ref. 10). 
As described previously (24), y-TM and yG35R-TM peptides form 
oligomers in the weak detergent PFO, but mutants of Gly-41 (yG41R-TM and 
yG41L-TM) do not. Using PFO-PAGE analysis (see ref. 24), we have confirmed 
that the yG35L-TM peptide can form oligomers in PFO (not shown), revealing a 
potential correlation between the effects of y peptides on K'Na and their ability to 
form oligomers in PFO. The physiological relevance of this observation remains 
to be investigated. 
Mimetic TM peptides reconstituted in detergent micelles have been used 
previously in structural studies of membrane proteins (11, 14,29) and have been 
shown to inhibit membrane protein function (6, 15, 22). However, to our 
knowledge, the resu]ts reported here constitute an unique example of a TM 
peptide that can display specific kinetic effects attributable to the TM domain of a 
membrane protein. The remarkable mimetic properties of the TM peptides and the 
expressed y mutants have particular significance. The failure of the G41R and 
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G41L mutants to affect K'Na, whether added as TM peptides to cell membranes or 
expressed as full-Iength proteins in transfected cells, underscores the conclusion 
that Gly-41 , which is associated with renal magnesium wasting when mutated to 
Arg, is important for the effect of the y subunit on K+ INa + antagonism and 
possibly for oligomerization of the protein, whereas Gly-35 is not. 
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CHAPTER4 
A structure/function analysis of a chain interaction with y 
117 
4.1 PREFACE 
This manuscript has been published in the Journal of Biological Chemistry and is 
titled "Regions of the Catalytic a Subunit of Na,K-ATPase Important for 
Functional Interactions with FXYD 2" (Zouzoulas, A. and Blostein, R. J. Biol. 
Chem. 281, 8539-8544, 2006). The goal of this study was to determine the 
region(s) of a that not only interact(s) with y, but are also important for the 
modulatory effects ofy. 
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4.2 ABSTRACT 
The y modulator (FXYD 2) is a member of the FXYD family of single 
transmembrane proteins that modulate the kinetic behaviour of Na,K-ATPase. 
This study concems the identification of regions in the a subunit that are 
important for its functional interaction with y. An important effect of y is to 
increase K+ antagonism of cytoplasmic Na + activation apparent as an increase in 
K'Na at high [K+]. We show that although y associates with al, a2 and a3 
isoforms, it increases K'Na of al and a3, but not a2. Accordingly, chimeras of al 
and a2 were used to identify regions of a critical for the increased K'Na. As with 
al and a2, aIl chimeras associate with y. Kinetic analysis of a2Fon,!ahack 
chimeras indicate that the C-terminal e07K_yIOI8) region of al, which includes 
TM 9 close to y, is important for the in crea se in K'Na. However, similar 
experiments with alFon,!a2back chimeras indicate a modulatory role of the loop 
between TM' s 7 and 8. Thus, as long as the aIL 7/8 loop is present, replacement 
of TM 9 of al with that of a2 does not abrogate the y effect on K'Na. In contrast, 
as long as TM 9 is that of al, replacement of L 7/8 of al with that of a2 does not 
abolish the effect. It is suggested that structural association of the TM regions of a 
and FXYD 2 is not the sole determinant of this FXYD's effect on K'Na, but is 
subject to long range modulation by the extramembranous L 7/8 loop of a. 
119 
4.3 INTRODUCTION 
The Na,K-ATPase or Na+ pump is an integral membrane prote in found in 
the ce Ils of virtually aIl higher eukaryotes. It couples the hydrolysis of one 
molecule of A TP to the electrogenic exchange of three intracellular Na + for two 
extracellular K+ ions against their electrochemical gradients. The Na+ pump is an 
oligomer of two subunits, a large catalytic a subunit and a smaIler, highly 
glycosylated J3 subunit whose role is to ensure the proper folding, insertion and 
maturation of a in the plasma membrane. Four isoforms of a and three of J3 are 
expressed in a tissue- and development-specific manner (for reviews, see refs. 15, 
16). 
The Na + pump is subject to diverse modes of regulation by substrates, 
membrane-associated components, hormones and neurotransmitters (30). In 
recent years, considerable attention has been focused on tissue-specific regulation 
by small transmembrane proteins referred to as FXYD proteins (for reviews, see 
refs. 5, 6, 10, 12). These proteins belong to a gene family of small, single 
transmembrane proteins, with the exception of Mat-8 which has two TM's. There 
are at least seven members of which several (FXYD's 1-4 and 7) appear to 
regulate the kinetic behaviour of the Na + pump in distinct and specific ways, in 
particular the apparent affinity of the enzyme for ligands (Na+, K+ and ATP). 
Members possess a 35 amino acid signature sequence that includes 6 invariant 
amino acids before, in and after the transmembrane (TM) domain. The N-
terminal FXYD (Phe-X-Tyr-Asp) motif is invariant, along with two glycines in 
the TM domain and a serine in the C-terminal domain. The first FXYD member 
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identified and characterized was y (FXYD 2), originally called the y "subunit" and 
present predominantly in the kidney. Other members include phospholemman 
(PLM or FXYD 1) Mat-8 (FXYD 3), CHIF (FXYD 4), RIC or Dysadherin 
(FXYD 5), Phosphohippolin (FXYD 6) and FXYD 7. A phospholemman-like 
prote in, PLMS, is present in the shark rectal gland. 
The y modulator exists as two main variants, ya and yb, with distinct as 
weil as overlapping localization along the nephron (26, 35). Mass spectrometry 
indicates that they differ only in the N-terminus (17). In rat ya, TELSANH is 
replaced by Ac-MDRWYL in yb. Previous studies in our laboratory (26, 27, 29, 
31, 32) using membrane fragments isolated from y-transfected rat al-HeLa cells 
have shown that y serves at least two distinct regulatory effects on pump kinetics 
and that the se effects are the same for both variants. Thus, (i) y increases the 
apparent affinity for ATP, (ii) increases K+lNa+ competition at cytoplasmic Na+ 
activation sites, as seen by an increase in K'Na at high [K+] concentration. In 
addition, in intact ceIls, y increases the apparent K+ affinity (3, 36). 
AIthough the functional effects of y on Na,K-ATPase have been 
extensively characterized, the structural basis of these effects is largely unknown. 
Earlier cryoelectron microscopy of the purified renal (aI131) pump (13) suggested 
that the y subunit is located in a pocket comprising TM 9, TM 6, TM 2 and 
possibly TM 4. Furthermore, recent homology modeling of the Na,K-ATPase 
based on the high resolution structure of the Ca-ATPase as weIl as cross-linking 
experiments have shown further that y makes contacts with TM 2, TM 6 and TM 
9 of the a subunit (8, 20). 
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An important issue concems the region(s) of a that interact(s) with the y 
modulator, focusing on the interactions that are critical for producing the 
modulatory effects of y. Mutagenesis of the al subunit (Ala replacement of 
Phe956 and Glu960) indicate the importance of TM 9 in affecting the apparent 
affinity for extracellular K+ (20). However, neither of these replacements 
abrogated the increase in K'Na effected ofy. 
The present study foc uses on regions of the a subunit with which y 
interacts to effect the increase in K'Na at high [K+] (K+/Na+ antagonism). Kinetic 
studies using y mutants (21, 27) and mimetic peptides comprising the 
transmembrane domain of y, y-TM (37), have clearly shown that the increase in 
K+/Na+ antagonism is mediated by the TM region ofy. Here we show that while y 
interacts with al, a2 and a3 and increases K' Na of a 1 and a3, a significant 
change in K'Na of a2 could not be detected. Accordingly, an al/a2 chimera 
approach was used to gain insight into regions of a which are relevant to its 
functional interaction with y resulting in increased K+/Na+ antagonism. 
122 
4.4 EXPERIMENTAL PROCEDURES 
Mutagenesis, Transfection, and Cel! Culture- AIl of the chimeric a' s used in this 
study were derived from the ouabain-insensitive rat al and a22 cDNAs (kindly 
provided by Jewell and Lingrel) introduced into the HindIII site of a modified 
pIBI shuttle vector. Using Stratagene's QuikChange Site-Directed Mutagenesis 
kit, silent mutations encoding for novel restriction sites were introduced into 
identical positions of rat a 1 and a2 cDNAs to create interchangeable restriction 
cassettes as described below. Chimeras al (1-311Y'a2 and a2(1_309)/al were prepared 
as described previously (28). Chimeras al(1_786ya2 and a2(1_783yal were 
prepared by introducing a MunI site which splits the codons for Ser-752 of al 
and the corresponding Ser-749 of a2 (the amino acid sequence is identical up to 
Leu-786 of a 1 and Leu-783 of a2) and by exchanging the 5' Sphl(334)-Munl(2491) 
restriction cassettes of al with the 5' Sphl(334)-Munl (2343) cassette of a2. 
Chimeras al(1_875ya2 and a2(1_872yal and al(1-907ya2 and a2(1_904yal were 
prepared as above, by introducing a NdeI site which splits the codon for Ala-848 
of al, corresponding to Ala-845 of a2. The amino acid sequence is identical up 
to Pro-875 of al (Pro-872 of a2). BsiWI was introduced as weIl, by splitting 
codons Thr-902 of al and the corresponding Thr-899 of a2 (the amino acid 
sequence is identical up to Lys-907 of al (Lys-904 of a2)). The 5' SphI(334)-
NdeI(278o) cassette of al was exchanged with the 5' SphI(334)-NdeI(2630) cassette of 
2 For simplicity, asterisks normally used to denote the ouabain-resistant forms of 
a2 and a3, i.e. a2* and a3* constructed by Jewell and Lingrel (14) are omitted. 
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a2 to create al(1_875)/a2 and a2(1-872lal. Similarly, the 5' SphI(334)-BsiWI(2944) 
cassette of al and the 5' SphI(334)-BsiWI(2792) cassette of a2 were exchanged to 
generate al(1_907)/a2 and a2(1-904)fal. The full-Iength cDNAs for aIl chimeric 
constructs were then excised from the shuttle vector using HindIII and ligated into 
pCDNA3.1. Orientation was confirmed by restriction analysis and full length 
cDNA sequences were verified. HeLa cells containing either the empty pIRES 
vector (HeLa-mock) or expressing yb protein (HeLa-yb-pIRES) (17) were 
transfected with the pCDNA chimeric a constructs using the LipofectAMINE 
technique (LipofectAMINE, Invitrogen). Cells expressing the relatively ouabain-
resistant rat a enzymes were then selected and maintained in culture as previously 
described (27). 
Membrane Preparations- NaI- and non NaI-treated microsomal membranes were 
prepared from the chimeric and WT cells as described earlier (14, 18). Prote in 
concentration was determined using a detergent-containing modification (23) of 
the Lowry method (22). 
Polyacrylamide Gel Electrophoresis and Western Blotting- SDS-PAGE and 
Western blotting were carried out as described previously (26). Following 
transfer of the SDS-PAGE gels to polyvinylidene fluoride (PVDF) membranes, a 
section of the membrane comprising the lower molecular size proteins (::S 28 kDa) 
was analyzed with a polyclonal y antibody (yC32) raised against the C-terminal 
KHRQVNEDEL peptide that is essentially the same as yC33 used previously 
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(26). The remaining membrane was blotted with monoclonal antibodies to detect 
the a subunit as described in the figure legends. 
Coimmunoprecipitation- The method used was a modification of Garty et al. (lI) 
as described elsewhere (37). Band densities were quantified using Molecular 
Dynamics ImageQuant software. 
Enzyme assays- Na+ dependent activation ofNa,K-ATPase activity was measured 
as described previously (27). Briefly, Na,K-ATPase activity was determined at 
100 mM KCl and varying concentrations of NaCI and with 10 !lM ouabain 
present to inhibit endogenous pumps. Baseline A TPase activity was determined at 
100 mM KCI and absence of NaCI, and with 100 mM choline chloride added to 
maintain a constant (200 mM) chloride concentration. For determination of the 
effects of the y-TM peptide on a2, the permeabilized membranes were assayed as 
previously described (37), except that the peptide concentration in the final assay 
mixture was 1.67 /lM. AIl experiments were carried out at least three times on two 
clones each ofmock- and y-transfected ceIls, with assays performed in triplicates. 
Data analysis- The data were analyzed using the Kaleidagraph computer pro gram 
(Synergy Software) with the noninteractive model of cation binding described by 
Garay and Garrahan (9), i.e. 
(1) 
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where v represents the rate of the reaction, Vmax is the maximal rate, and K'Na is 
the apparent affinity for Na+. Superscript 3 denotes the number of Na+ binding 
sites. Values of Vmax and K'Na were obtained from this fitting procedure. 
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4.5 RESULTS 
Earlier studies with cRNA injected Xenopus oocytes showed that the y 
subunit can associate with the three major isoforms of the a subunit (3). In the 
present study, this finding was confirmed with mammalian cells. For these 
experiments rat a1-, a2- and a3- HeLa cells were transfected with y (yb variant) 
and following isolation of stable transfectants, membranes were isolated, 
solubilized with detergent and subjected to immunoprecipitation with anti-y 
antibodies using the conditions deve10ped by Garty et al. (11) as outlined in 
Experimental Procedures. These authors showed that coimmunoprecipitation is 
efficient only in conditions (solublization in C12EIO in the presence of either Rb + + 
ouabain as used here, or Na+ + oligomycin) that preserve native pump structure 
(11). Samples taken before and after immunoprecipitation were subjected to SDS-
PAGE and Western blotting with anti-a-specific antibodies as indicated. The 
results (Fig. 4-1) show that al, a2 and a3 associate with y since all are 
immunoprecipitated by anti-y antibodies. As shown by Lindzen et al. (21) a 
relatively small fraction (::::;5%) of the total prote in is precipitated un der these same 
conditions. As indicated in the legend to Fig. 4-1, quantitation of the bands 
indicates that the efficiency of immunoprecipitation is similar (::::;6%) for all three 
isoforms. 
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Fig. 4-1: Coimmunoprecipitation of a isoforms with y. Membranes were 
solubilized and immunoprecipitated with anti-C-terminal antibody yC32 as 
described in Experimental Procedures. Aliquots corresponding to 51lg and 45 Ilg 
of the original solubilized protein taken before (-) and after immunoprecipitation 
(+), respectively, were resolved by SDS-PAGE and analyzed by Western blotting 
using the following monoclonal antibodies: for the upper section of the blot, A277 
(Sigma) for al, McB2 (gift of Dr. K. Sweadner) for 0.2 and A273 (Sigma) for 0.3; 
for the lower section, yC32 to detect y. Efficiencies of coimmunoprecipitation as 
determined by densitometry of the bands (ratio of the a/y density post-
immunoprecipitation/pre-immunoprecipitation) were 6.2% for alyb, 5.9% for 
a2yb and 6.2% for a3yb. 
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Effects of r on the Na + activation kinetics of the a isoforms 
Although y associates with aIl three isoforms of a, the question remains 
whether the y-mediated increase in K+/Na+ antagonism se en previously for al 
also holds true for a2 and a3. In the experiments described below, Na,K-ATPase 
activity for a 1 and a2 was measured with NaCI varied and KCI kept constant at 
100 mM. a3 was assayed at 50 mM KCI since K'Na ofWT a3 is high (16.5 mM 
at 100 mM K+; see ref. 24) and even higher with a3-yb membranes, preduding 
satisfactory extrapolation to V max. The results presented in Table 4-1 show that 
whereas y increases K'Na of al and a3 by almost ;::::1.6-fold, a significant change 
in K' Na of a2 could not be detected. It is noteworthy that like the effect of full 
length y, the transmembrane mimetic peptide of WT y (y-TM) increases K'Na of 
al but not a2. 
The lack of K'Na modulation of a2 pumps by y, in spite of the high 
sequence identity between al and a2, provided a unique opportunity to use an 
a lIa2 chimera approach to identify regions of a interaction with y which are 
functionally important for the K'Na effect. Fig. 4-2 depicts a linear representation 
of the al-front half/a2-back half (a1Ja2b) and the reverse a2-front half/al-back 
half (a2/al b) chimeras used for these experiments. The high degree of amino 
acid identity (86%) among the isoforms notwithstanding, the regions of most 
diversity between a 1 and a2 are within residues 1-311 and 429-565 (a 1 
numbering), which span the cytoplasmic N-terminus and part of the large 
cytoplasmic loop between TM 4 and TM 5 (see top of Fig. 4-2). 
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Table 4-1: Isoform specificity of the y-mediated modulation of K+/Na+ 
antagonism 
K'Na (mM) 
Membranes mock -transfected yb-transfected Fold increase 
(yb/control) 
al** 5.3 ± 0.3 8.3 ± 0.1 1.6* 
a2 9.3 ± 0.7 9.5 ± 1.2 ~ 1.0 
a3 9.3 ± 1.4 16.6 ± 1.1 1.8* 
no addition plus y-TM 
aIt 4.8 ± 0.2 15.4±0.8 3.2* 
a2 8.1 ± 0.7 6.9± 0.7 ~ 1.0 
K'Na was measured at either 100 mM K+ (al, (2) or 50 mM K+ (a3) and 
represents the average of at least three experiments (average ± SEM) 
* p~ 0.01 compared to control 
** data taken from Pu et al. 2001 (26) 
t data taken from Zouzoulas et al. (37) 
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Fig. 4-2: Schematic illustration of the al and a2 chimeras. Regions of 
greatest divergence are indicated by the brackets above al (al numbering 
beginning with the mature N-terminus, GRDKY). 
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Association of ywith al/a2b and a2/a1b chimeras and ifs effects on their Na+ 
activation kinetics 
The coimmunoprecipitation experiment shown in Fig. 4-3 indicates that 
similar to its association with a 1 and a2 (see Fig. 4-1), yb associates with all 
al.la2b and a2Jalbchimeras. 
In the experiments depicted in Fig. 4-4, the effects of y on the apparent 
K'Na of al.la2b and a2/alb chimeras were measured at 100 mM K+ and 
compared with the effects of y on WT al and a2 isoforms. Fig. 4-4 (top panel) 
shows representative graphs of a2 and a2Jah chimeras and Fig. 4-4 (bottom 
panel) shows chimeras in the reverse alJa2b configuration. Fig. 4-5 summarizes 
the results of the averages of replicate experiments carried out as shown for the 
representative experiments in Fig. 4-4 (see absolute values presented in Table 4-
2). 
Fig. 4-4 (top panel), Fig. 4-5 and Table 4-2 indicate that y causes a 
significant increase in the K'Na of all chimeras in the a2/alb configuration, 
similar to that reported for WT al. It is notable that this holds true for chimera 
(a2(1_904yal) comprising only TM's 8-10 of al and thus encompassing TM 9 
which has been shown to be close to (13), and to interact with y (8, 20). 
As shown in Fig. 4-4 (bottom panel), Fig. 4-5 and Table 4-2, y did not 
increase K'Na of chimeras al.la2b up to al(l_875ya2, similar to its lack of effect on 
the WT a2 enzyme. However, a notable y-mediated increase in K'Na of al(l_ 
907)fa2 was observed. This latter effect of y was not seen at low (10 mM) K+ 
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concentration (experiment not shown) indicating that like WT al (27), the y-
mediated increase in K'Na of the al(l_907ya2 chimera reflects increased 
cytoplasmic K+/Na+ antagonism. Taken together and as discussed below, these 
observations suggest that the extracellular loop between TM 7 and TM 8 (L 7 /8) 
has a role in modulating the effect of y on K'Na. 
Although Table 4-2 shows that there are notable differences in K'Na values 
of mock-transfected al, a2 and chimeras thereof, it is clear that the y-mediated 
increases in K'Na are independent of these intrinsic differences. 
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Fig. 4-3: Coimmunoprecipitation of al and a2 chimeras with y. Experiments 
were carried out as described in Fig. 4-1. Each lane was loaded with protein 
corresponding to an activity (V max) of :::::;25 nmoles/min of the original solubilized 
sample. Top panel represents y-a association of a2 wild type and a2/alb 
chimeras while the bottom panel represents al wild type and aIla2b chimeras. 
For Western blots, the following monoclonal antibodies were used to detect the a 
subunit chimeras: for the a2;1alb chimeras, McB2; for the aIla2b chimeras, 
McKI for al (l_3I-1ya2 and ail others, with A277 (Sigma). 
136 
137 
Fig. 4-4: Effects of y on Na+ activation of Na,K-ATPase of forward and 
reverse a.1Ia.2 chimeras. Membranes were isolated and assays were carried out 
at 100 mM KCI and varying concentrations ofNaCI as indicated in Experimental 
Procedures. Data points shown are means ± S.D. (triplicate deterrninations) of 
representative experiments and are expressed as percentages of Vmax• Top panel, 
a2 and a2lalb chimeras. Bottom panel, al and a1la2b chimeras. Dashed fine, 
mock-transfected cells. Safid Une, y-transfected cells. 
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Fig. 4-5: Summary of effects of y on K'Na of al, 0.2, a1Ja2b and a21ah 
chimeras. Data are taken from Table 4-2 and are expressed as the percent 
increase in K'Na caused by y. 
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Table 4-2: Summary of the effects of Y on K'Na 
K'Na (mM) 
C'ELLS a2 al(l_3II!a2 al(1_786!a2 al(1_875!a2 al (I-907!O 
mock 8.9 ± 0.4 (7) 9.3 ± 0.7 (4) 4.7 ± 0.2 (7) 5.2 ± 0.3 (5) 6.8 ± 0.4 
yb-tf 9.7 ± 0.4 (7) 9.5 ± 1.2 (4) 5.4 ± 0.2 (9) 5.3 ± 0.1 (5) 9.4 ± 0.6* 
a1** a2(1_309!a1 a2(1_783!a1 a2(1_872!a1 a2(1-904!O 
mock 5.3 ± 0.3 8.2 ± 0.4 (4) 13.9 ± 0.4 (6) 12.7 ± 1.2 (5) 7.3 ± 0.4 
yb-tf 8.3 ± 0.1 * l1.6±0.9* (4) 17.5 ± 0.8* (7) 18.8 ± 0.4* (5) 12.2 ± 1.4* 
Na,K-ATPase assays were_carried out as described in Fig. 4-4. Each value is the 
mean ± SEM of the number ofseparate experiments shown in brackets. 
Vrnax values (nmol/mg/min) for a2, a1(1_3II!a2, a1(1_786!a2, al(1_875)/a2 and a1(1_ 
907!a2 were 300±20, 81±7, 212±48, 270±22 and 224±16, respectively, for mock-
transfected cells and 277±17, 120±9, 121±6, 298±30 and 257±46, respectively, 
for yb-transfected cells. 
Vrnax values (nmol/mg/min) for al, a2(1_309!a1, a2(1-783la1, a2(1-872la1 and a2(1_ 
904)/al were 375±25, 177±11, 253±78, 250±12 and 168±6, respectively, for 
mock-transfected cells and 520±196, 244±26, 330±26, 405±17 and 192±2, 
respectively, for yb-transfected cells. 
* p-:;' 0.01 compared to mock-transfected 
** data taken from Pu et al. 2001 (26) 
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4.6 DISCUSSION 
Earlier studies showed that the y modulator has distinct kinetic effects on 
the Na,K-ATPase of cultured mammalian cells such as rat al-transfected Hela 
cells transfected with either ya or yb. One effect is a y-mediated increase in the 
apparent ATP affinity (31, 32). Another effect is a y-mediated increase in K'Na at 
high K+ concentration (26, 27) due to an increase in K+ antagonism of 
cytoplasmic Na + activation, which can have a significant effect under 
physiological conditions in which the intracellular Na + concentration limits the 
rate of pump activity. (For further discussion of the physiological importance of 
this y effect, see ref. 10). It is noteworthy that these differences in apparent 
affinities are consistent with the differences in affinities seen with al f31 pumps in 
y-rich kidney preparations compared to y-free tissues (29). An additional distinct 
effect, observed only in intact HeLa cells, is an increase in apparent affinity for 
extracellular K+ (36). This effect may be similar to a membrane potential-
dependent decrease in K(05)K reported with Xenopus oocytes bathed in Na+-
containing medium (l, 3). 
Regions of r important for modulation of ligand ajJinities 
Distinct regions of y are important for its aforementioned distinct effects. 
The cytoplasmic C-terminus is responsible for the y -mediated decrease in K' ATP. 
This effect has been localized to its penultimate four residues (27) since their 
deletion abrogates the decrease in K' ATP. However, this y effect can be modified 
by long range perturbations as seen in experiments in which the effect was 
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abrogated by deletion of the first seven residues from the extramembranous N-
terminus (mutant ybN~7; ref. 27). The y-mediated increase in K'Na has been 
attributed to the y-TM domain al one (37) since a y-TM peptide that is devoid of 
extramembranous regions elicits this property (also see Table 4-1) and a 
disruptive mutation in the TM helix (ybG4IR) abrogates the y effect ofboth full 
length y (27) as well as y-TM (37). 
Regions of a involved in functionally important r-afJ associations 
Several earlier studies have provided insight into regions of a with which 
y associates. Thermal denaturation experiments suggested a region between TM' s 
8-10 (7). Cryoelectron miscroscopy (13) as well as homology modeling (20) 
based on SERCA-Phospholamban interaction (33) have pointed to the importance 
of TM 2, TM 6 and TM 9. 
Regions of y-af3 pump interaction relevant to the kinetic effects of y are 
only beginning to be identified. Recent mutagenesis studies have indicated the 
importance of TM 9 in abolishing the functional effect of y on the voltage 
dependence of K+ affinity seen in y cRNA-injected oocytes (20). The present 
study focuses on regions of the a subunit which interact with y to effect its 
modulation of K'Na. The results with a2/alb chimeras are consistent with a key 
role of TM 9 in mediating the K+ antagonism of cytoplasmic Na+ activation. Thus, 
the y-mediated increase in K'Na at high K+ concentration, characteristic of its 
effect on al, is seen with all a2/alb chimeras including chimera a2(l-904lal. In 
the C-terminal portion (residues 907-1018 ofal), only TM 9 is proximal to y (8, 
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13,20). Even if one considers aIl a TM's near y, namely TM 2, TM 6 and TM 9 
as in the model of Fusezi et al. (8), and possibly TM 4 seen by cryo-electron 
microscopy (13), it is notable that amino acid sequences of TM 4 and TM 6 of al 
and a2 are identical. ln TM 2, only one of the three conservative differences 
between a2 and al is also different between a2 and a3, yet y increases K'Na of 
both al and a3, but not a2. In TM 9, there is one non-conservative residue 
difference in a2, namely Leu95 1 in a2 is Phe in both al and a3. This difference 
may be key to the functional importance of TM 9. The putative importance of 
TM 9 notwithstanding, the effects of y on K'Na of the reverse a1/a2b suggest that 
its role is modified by extramembranous region(s) as discussed below. 
RoZe of the L 7/8 Zoop 
Similar to the lack of its effect on WT a2, y does not increase K'Na of the 
alla2b chimeras up to al(l_875)ia2 whereas like its effect on WT al, y increase 
K'Na of al(l_907)/a2. Thus, replacement of residues 873SRLLGIRLDWDDRTT887 
in the extracellular L 7 /8 loop of a2 with the analogous residues of al 
(876FHLLGIRETWDDRWI890)3, points to an important but complex role of the 
L 7 /8 loop. Thus, as long as the aIL 7 /8 sequence is present, replacement of TM 9 
of al with that of a2 does not abrogate the y-dependent increase in K'Na. On the 
other hand, as long as TM 9 is that of al, replacement of the aIL 7 /8 sequence 
3 a2 versus al isoform-distinct residues in the aforementioned peptides are 
underlined. 
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with the analogous sequence of a2 does not abolish the K'Na effect. Interestingly, 
there are six non-conservative residue differences between al and a2, sorne of 
which presumably underlie the isoform-distinct effect of y on K'Na. 
The aforementioned role of L 7/8 loop may not be surprising. This loop 
appears to be the focal region for y-a-J3 interactions. Accordingly, at the 
extramembranous extracellular region, the 13 subunit interacts with L 7/8 of a 1 as 
shown in several earlier studies (4,8, 19,25,34) and y can also be cross-linked to 
13 (8), and as already suggested (8), the site of y-J3 interaction is probably close to 
the site of a-J3 interaction. 
Although the a 1 versus a2 difference in L 7/8 is probably key to the loss 
of the y effect in a2, the effect must be long range, quite likely affecting 
associations within the membranous regions since the isoform-distinct effects of y 
are seen in the present study in which addition of only the transmembrane region 
of Y increased K'Na ofal but not a2 pumps (see Table 4-1). It is noteworthy that, 
like y, the functional effects of FXYD7 are also isoform specific (2)". Like y, 
FXYD 7 associates with al, a2 and a3 but its effect on affinity for K(05)K 
(decrease in apparent affinity) is seen with al and a2, but not a3. Similarly to y, 
FXYD 7 resides in a groove made up ofTM's 2, 6, and 9 of the a subunit (20). 
Conclusions 
Our findings support the Vlew that structural associations of 
transmembrane regions of the catalytic a subunit with FXYD proteins are not 
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necessarily the sole determinants of the kinetic effects of these regulators on 
cation affinities. In the case of y, the extramembranous L 7/8 Ioop of a appears to 
modulate intramembranous a-y interactions to effect the y-mediated increase in 
K+ antagonism of cytoplasmic Na + activation. 
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CHAPTER5 
GENERAL DISCUSSION 
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Na,K-ATPase activity is subjected to both acute and long-term regulation 
by a variety of physiological factors. The mechanisms of Na,K-ATPase 
regulation are diverse (16, 38, 134) and include the modulation by its association 
with other intrinsic membrane proteins. FXYD proteins comprise a gene family 
of small, single transmembrane proteins that are abundant and widespread in 
mammalian tissues and represent a nove! mechanism for tissue specific regulation 
of the Na,K-A TPase. They are distributed in a variety of cells including epithelial 
cells and cells of the neuromuscular system. 
The last decade has provided a significant amount of insight into the 
functional role of FXYD proteins interactions with the Na,K-ATPase. 
Coimmunoprecipitation of FXYD proteins with the Na,K-ATPase and their 
distinct modulation of ligand affinities, seen in membrane preparations of various 
FXYD-bearing cells, expression systems, and to sorne extent, studies with knock 
out (KO) mice have provided insight into the function of FXYD proteins. 
Recently results with three FXYD proteins obtained from studies in KO mice 
confirm, at least to sorne extent, FXYD modulation of Na,K-ATPase seen in in 
vitro studies. 
5.1 FXYD interactions with aB subunits 
While y, CHIF and FXYD 7 appear to be isoform-specific regulators of 
the Na,K-ATPase exclusively modulating al in vivo, two other FXYD members 
have been shown to associate with a2 and a3 as weIl. For instance, PLM has 
been shown to associate with and modulate more than one a isoform in native 
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tissue. In native cardiac and skeletal muscle, PLM interacts predominantly with 
all3 (31, 43, 127) and to a lesser extent a213 isoforms (31). Functional studies 
showed that with both al131 and a2131, PLM decreases the affinities for both 
intracellular Na + and extracellular K+ when expressed in Xenopus oocytes (31). 
Association of PLM to aIl three a isoforms was also detected in cerebeIlum in 
neurons, astrocytes and glial cells (40). The physiological relevance of the 
association of PLM with more than one catalytic isoform at a time in either 
cardiac or brain tissue is unclear. It has been shown that PLM KO mice exhibit an 
increased ejection fraction, an increase in cardiac mass without hypertension and 
a decrease in maximal enzymatic activity (59). Although PLM had been detected 
in the CNS (40), the KO phenotype described seems to suggest that PLM's 
primary role may be in regulation of Na,K-A TPase in cardiac muscle. 
Interestingly FXYD 7 is also found in neurons and glial ceIls of the brain (12) and 
may play a more important role in the hrain than PLM. PLMS associates with 
and regulates the a3 isoform in native tissue (see Table 1-2). 
5.2 Regulation of the apparent affinity for ligands by the y modulator 
The y modulator of the Na,K-ATPase is a primary example of a small 
single transmembrane protein with a key regulatory role. First to be discovered 
and subsequently characterized, the y subunit can be considered as a 'model' of a 
FXYD prote in with a tissue-specific (mainly renal) modulatory function. As 
summarized in Table 1-2 and from the present studies it may he concluded that y 
serves at least three distinct functions in regulating the a 1131 pumps, namely (i) an 
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increase in K'Na, (ii) a decrease in K' ATP and (iii) decrease in KO.5(K) se en only in 
hyperpolarized Xenopus oocytes (11, 13) and intact y-transfected rat-al HeLa 
celIs (Chapter 2). 
While the functional effects of y have been weIl established, the 
physiological relevance of y is still unknown. Gamma KO mice are viable and 
show no phenotype (62), despite y's association with renal magne sium wasting 
disease in humans (100, 101) and y's absence during embryonic development 
which was shown to be essential for blastocoel formation in mice (60). In 
membranes prepared from KO mice, y's effect on apparent Na+ affinity (i.e. 
increase in K'Na) was observed while the apparent increase in ATP and K+ affinity 
was not. Not surprisingly, no effect on K05(K) was seen since these authors only 
tested fragmented membrane preparations. The absence of the K' ATP effect is 
more puzzling. It would be interesting to test whether differences in membrane 
preparation protocols can account for this discrepancy. Membranes prepared 
from KO mice were purified using the Jorgensen method (63) which requires 
incubation with SDS in the presence of A TP whereas membrane preparations 
used in my experiments as weIl as earlier ones from our laboratory (114, 115) 
used the (ATP- free) Na! method described in refs. (58, 74). Intact y transfected 
rat al-HeLa celIs show a greater increase in K+ influx as a function of [A TP] 
compared to mock transfected celIs (see Chapter 2). 
That the decrease in apparent Na+ affinity seen at high K+ concentrations 
is physiologically relevant was supported by studies with intact cells showing an 
increase in steady-state intracellular Na + concentration ([Na +]in). This effect was 
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only seen in rat al-HeLa cells transfected with yb compared to control; 
presumably an effect on ya was not detected due to the higher V max of ya clones 
compared to control mock transfected cells which would obscure a change in 
[Na+]in due to the kinetic effect (increase) on K'Na (see Results and Discussion in 
Chapter 2 for details). Consistent with our findings in intact yb-transfected cells, 
[Na +]in levels in renal cells measured by electron microprobe analysis, were noted 
to be higher in nephron segments with highest expression of y (mTAL) and lowest 
[Na+]in levels in segments that are devoid of y (CCD principal cells) (7, 8). Since 
a notably higher intracellular Na + is seen in cells under the A TP-replete conditions 
used in studies in Chapter 2, a decrease in K' ATP could presumably oppose an 
increase in K'Na. It may be of value to determine whether the relative increase in 
intracellular Na + is less apparent when the intact cells are energy-deprived. 
5.3 Does y have a role other than kinetic modulation of the Na,K-A TPase at the 
plasma membrane? 
When y alone was expressed in Xenopus oocytes, it was able to induce ion 
currents. The magnitude of these ion currents remained unaffected upon 
coexpression with exogenous a and ~ subunits (103). Sha et al. (122) also 
reported that human y in oocytes can activate Ca2+ and voltage-gated, non-
selective large diameter pores that are intrinsically present on the oocyte 
membrane. 
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The physiological implication of the presence of the two variants with 
distinct as weil as overlapping expression along the nephron remains to be 
determined. While no functional differences have been detected in assays using 
either permeabilized membranes (114) or intact cells (see Chapter 2), it has been 
shown that ya and not yb is upregulated when exposed to NaCI, heat shock and 
stress, suggesting a role for at least one of the variants in the cell's response to 
stress (145). It has also been suggested that ya may differentially target the Na,K-
ATPase to caveolae, microdomains of the plasma membrane where signaling 
cascades are initiated (39). 
To-date, the effect of y on cell surface expression has only been addressed 
cursorily (IlS). For example, the question ofwhether y association to the Na,K-
A TPase affects the rate of pump trafficking and, if so, whether the two variants 
have a distinct role in pump protein turnover at the ceIl surface has not been 
addressed. Although early studies showed that y leaves the ER with al3 to be 
delivered to the plasma membrane (13), those experiments were performed with 
only one variant, ya, with an erroneously extended N-terminus, as discussed in 
(11). 
5.4 Role of the transmembrane segment of y in modulating Na,K-ATPase 
function, with emphasis on the effect of mutation G41R 
In 2000, Meij et al. reported that a dominant negative point mutation in the 
TM region of the human y subunit is associated with renal magnesium wasting. 
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Their immunofluorescence studies showed that y does not appear at the surface of 
either transfected Sf-9 ceIls or COS ceIls and suggested that a trafficking to the 
ceIl surface was also affected. In a later study, using rat y- and yG4IR-
transfected rat al-HeLa ceIls Pu et al. (115) showed that whereas the G41 R 
mutation prevented appearance of y at the plasma membrane, surface expression 
of a was unaffected. ResuIts with peptides provide direct evidence of the primary 
effect of G4lR to be failure to interact with a (see Chapter 3). From these 
aforementioned studies, whether or not the misrouted yG41R mutant, aIters aJ3 
pump rates of trafficking/tumover is unclear. 
In view of the dominant negative effect of the G4lR mutation and the 
evidence that y- but not G4IR- TM peptides form dimers (135), it would be 
important to determine whether the dominant negative effect of yG41R can be 
explained by an abrogation of dimerization. AIthough our studies failed to reveal 
y oligomers in PFO-PAGE, it remains plausible that y-y association is relevant to 
y-aJ3 interaction at the subcellular level (i.e. ER, Golgi) in which case an effect of 
yG4lR on y trafficking (abrogation) to the cell surface may occur. This might be 
approached by experiments with cells transiently transfected with y and yG4IR, 
separately and together, with subsequent determination of a-y association 
(coimmunoprecipitation) as weIl as a and y expression at the ceIl surface (surface 
biotinylation). This may provide information relevant to the question ofwhether 
dimerization has a function in normal y processing or possibly stabilization of aJ3y 
oligomers at the plasma membrane. 
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5.5 Sites of a-y interaction 
While interaction of y' s TM domain alone with the al subunit can elicit 
the K'Na effect (result in Chapter 3), results in Chapter 4 indicate that the 
interaction of a with y is complex and long range. Replacement of residues 
873SRLLGIRLDWDDRTT887 in the extracellular loop of L7/8 of a2 with the 
analogous residues of al (876FHLLGIRETWDDRWI890), provides evidence of a 
role of the L7/8 loop in long range modulation ofK'Na. These 'non-conservative' 
residue differences (underlined above) may be responsible for this long range 
effect of the isoform-specific modulation of the y-mediated increase in K'Na. The 
L7/8 loop is probably the 'structural crossroad' of y-aJ3 interactions. At the 
extramembranous extracellular region, the 13 subunit interacts with L 7/8 of a 1 as 
shown in several eariier studies (29, 77, 110, 144) and y can also be cross-linked 
to 13 (44), and as already suggested (44), the site of y-J3 interaction is probably 
close to the site of a-J3 interaction. Although these studies with al/a2 chimeras 
indicate the importance of the C-terminus of a 1 in K+ /Na + antagonism effected by 
y, it would be of interest to specifically pin-point which residue(s) in L7/8 is 
responsible for long range modulation ofK'Na. 
5.6 Future Perspectives 
In the future, it is likely that additional families of transport modulator 
proteins will be identified among the many "orphan" genes present in many 
genomes. Recently, one such member has been defined. A yeast two-hybrid 
screen identified the 131 and 133 subunits of the Na,K-ATPase as MONaKA 
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(modulator of Na, K-ATPase) binding partners (96). The interaction between 
MONaKA and Na,K-ATPase f3 subunits was detected in transfected tsA201 cells 
derived from HEK293 cells, mouse brain, and cultured mouse astrocytes. These 
studies indicated a decrease in Rb + influx following transfection. 
The experimental evidence gathered over the years has established the 
FXYD family of small single TM proteins as tissue specifie modulators of the 
Na,K-ATPase. More studies are needed to better understand their physiological 
relevance and the implications of the potential loss of FXYD modulation of the 
Na,K-ATPase in disease states. Likewise, although the mechanistic basis for 
renal magnesium wasting by the yG41R mutation remains unknown, it may 
indicate an indirectlsecondary role of the Na,K-ATPase in causing this disease 
and further underscores the fundamental importance of the Na,K-ATPase in the 
maintenance of secondary transport processes. 
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